About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
901 genotypes with 1237 annotations displayed of selected term and subterms
Searched Term: seizures
Allelic Composition
(Genetic Background)		 Annotated Term Reference
Achetm4Pata/Achetm4Pata
(involves: 129X1/SvJ * Black Swiss * C57BL/6 * FVB) 		seizures J:147855
Acp2tm1Psa/Acp2tm1Psa
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J) 		tonic-clonic seizures J:41986
Adam22tm1Sag/Adam22tm1Sag
(either: B6.Cg-Adam22tm1Sag or (involves: C57BL/6 * C57BL/6N * CBA)) 		convulsive seizures J:99692
Adamts4tm1Dgen/Adamts4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Adarb1tm1Phs/Adarb1tm1Phs
(involves: 129S1/Sv * 129X1/SvJ) 		seizures J:63273
Adgrv1frings/Adgrv1frings
(RB/1) 		audiogenic seizures J:25341
Adgrv1frings/Adgrv1frings
(BUB/BnJ) 		audiogenic seizures J:97534
Adgrv1tm1Msat/Adgrv1tm1Msat
(involves: 129P2/OlaHsd * C57BL/6J) 		audiogenic seizures J:95518
Adgrv1tm1Msat/Adgrv1tm1Msat
(B6.129P2-Adgrv1tm1Msat) 		audiogenic seizures J:95518
Adgrv1tm1Pwh/Adgrv1tm1Pwh
(involves: 129S1/Sv * C57BL/6J) 		audiogenic seizures J:90899
Adktm2Bois/Adktm2Bois
Adora1tm1Bbf/Adora1tm1Bbf
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		environmentally induced seizures J:237189
Adktm2Bois/Adktm2Bois
Adora2atm1Jfc/Adora2atm1Jfc
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * SJL) 		decreased susceptibility to induction of seizure by inducing agent J:237189
Adktm2Bois/Adktm2Bois
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		convulsive seizures J:237189
environmentally induced seizures J:237189
increased susceptibility to pharmacologically induced seizures J:237189
Adora2btm1.1(KOMP)Vlcg/Adora2b+
(B6N(Cg)-Adora2btm1.1(KOMP)Vlcg/J) 		convulsive seizures J:211773
Adra2atm1Bkk/Adra2atm1Bkk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal spike wave discharge J:197965
Agpat1tm1Garg/Agpat1tm1Garg
(involves: 129S6/SvEvTac * C57BL/6) 		audiogenic seizures J:250301
Aifm1Hq/Y
(B6CBACa Aw-J/A-Aifm1Hq/J) 		abnormal seizure response to pharmacological agent J:98103
Aifm1Hq/Aifm1Hq
(B6CBACa Aw-J/A-Aifm1Hq/J) 		abnormal seizure response to pharmacological agent J:98103
Akap5tm1.1Jsco/Akap5tm1.1Jsco
(involves: 129S * C57BL/6 * FVB/N) 		decreased susceptibility to pharmacologically induced seizures J:138972
Akt3Nmf350/Akt3+
(C57BL/6J-Akt3Nmf350) 		abnormal seizure response to electrical stimulation J:169028
increased susceptibility to pharmacologically induced seizures J:169028
maximal tonic hindlimb extension seizures J:169028
sporadic seizures J:169028
tonic-clonic seizures J:169028
Akt3Nmf350/Akt3Nmf350
(C57BL/6J-Akt3Nmf350) 		abnormal seizure response to electrical stimulation J:169028
increased susceptibility to pharmacologically induced seizures J:169028
maximal tonic hindlimb extension seizures J:169028
tonic-clonic seizures J:169028
Akt3tm1Mbb/Akt3tm1Mbb
(involves: C57BL/6J) 		abnormal seizure response to electrical stimulation J:169028
maximal tonic hindlimb extension seizures J:169028
tonic-clonic seizures J:169028
Aldh5a1tm1Kmg/Aldh5a1tm1Kmg
(involves: 129/Sv * C57BL/6) 		absence seizures J:91856
myoclonus J:71949
tonic seizures J:71949
Alg13em1Bayu/Y
(involves: C57BL/6J) 		environmentally induced seizures J:275180
increased susceptibility to pharmacologically induced seizures J:275180
Alpltm1Jlm/Alpltm1Jlm
(either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6J)) 		seizures J:39015
Alpltm1Sor/Alpltm1Sor
(either: (involves: 129S7/SvEvBrd-Alpltm1Sor) or (involves: 129S7/SvEvBrd * C57BL/6)) 		seizures J:28394
Amphtm1Pdc/Amphtm1Pdc
(involves: 129/Sv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:75306
tonic seizures J:75306
Ank3tm1Bnt/Ank3tm1Bnt
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		convulsive seizures J:51377
Ap3b2m1J/Ap3b2m1J
(C57BL/6J-Ap3b2m1J/FrkJ) 		tonic-clonic seizures J:205908
Ap3b2m2J/Ap3b2m2J
(B6;129S-Ap3b2m2J/GrsrJ) 		tonic-clonic seizures J:222308, J:205908
Ap3b2tm1Bur/Ap3b2tm1Bur
(C57BL/6-Ap3b2tm1Bur) 		tonic-clonic seizures J:94942
Ap3d1mh-2J/Ap3d1mh-2J
(involves: C3H/HeJ * C57BL/6J * CAST/Ei) 		abnormal spike wave discharge J:59842
Ap3d1mh/Ap3d1mh
(STOCK Mfsd12gr +/+ Ap3d1mh/J) 		abnormal spike wave discharge J:59842
Ap3m2tm1Ohno/Ap3m2tm1Ohno
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal kindling response J:93312
increased susceptibility to pharmacologically induced seizures J:93312
nonconvulsive seizures J:93312
seizures J:93312
Apc2tm1Mno/Apc2tm1Mno
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:184856
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc) 		abnormal kindling response J:118390
Arf4tm1.1Tsdk/Arf4+
Arf5tm1.1Tsdk/Arf5tm1.1Tsdk
(B6J.B6N-Arf4tm1.1Tsdk Arf5tm1.1Tsdk) 		abnormal spike wave discharge J:279779
Arhgap32tm1Taki/Arhgap32tm1Taki
(B6N.Cg-Arhgap32tm1Taki) 		increased susceptibility to pharmacologically induced seizures J:236753
Arv1tm1.2Geno/Arv1tm1.2Geno
(involves: C57BL/6 * C57BL/6J) 		seizures J:263695
Arxtm1.1Jno/Y
(involves: 129S7/SvEvBrd * C57BL/6J) 		clonic seizures J:151082
myoclonus J:151082
seizures J:151082
tonic-clonic seizures J:151082
Arxtm1.1Jno/Arxtm1.1Jno
(involves: 129S7/SvEvBrd * C57BL/6J) 		myoclonus J:151082
Arxtm1Gldn/Y
Tg(mI56i-cre,EGFP)1Kc/0
(involves: 129/Sv * C57BL/6 * CD-1 * FVB/N) 		clonic seizures J:148311
sporadic seizures J:148311
tonic-clonic seizures J:148311
Arxtm1Gldn/Arx+
Tg(mI56i-cre,EGFP)1Kc/0
(involves: 129/Sv * C57BL/6 * CD-1 * FVB/N) 		clonic seizures J:148311
convulsive seizures J:148311
sporadic seizures J:148311
tonic-clonic seizures J:148311
Arxtm3Kki/Y
(involves: 129S/SvEv * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:152416
Arxtm4Kki/Y
(involves: 129S/SvEv * C57BL/6J) 		abnormal spike wave discharge J:152416
seizures J:152416
tonic seizures J:152416
Arxtm4Kki/Y
(involves: 129S/SvEv * C57BL/6NHsd) 		myoclonus J:260340
Arxtm5Kki/Y
(involves: 129S/SvEv * C57BL/6NHsd) 		myoclonus J:260340
seizures J:260340
Asp1/Asp1
(DBA/2J) 		audiogenic seizures J:6355
Asp2/Asp2
(DBA/2J) 		audiogenic seizures J:11261, J:5094
Asp3DBA/2J/Asp3DBA/2J
(DBA/2J) 		audiogenic seizures J:11261
Aspanur7/Aspanur7
(involves: C57BL/6J) 		seizures J:226682, J:143201
Atad1tm1.1Vdaw/Atad1tm1.1Vdaw
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6) 		seizures J:173768
Atad1tm1Vdaw/Atad1tm1Vdaw
Tg(Camk2a-cre)2Gsc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		seizures J:173768
Atcayji/Atcayji
(Not Specified) 		seizures J:14903
Ate1tm1Avar/Ate1tm2.1Avar
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		seizures J:155421
tonic-clonic seizures J:155421
Atox1Gt(IRESBetageo)3Pgr/Atox1Gt(IRESBetageo)3Pgr
(B6.129(Cg)-Atox1Gt(IRESBetageo)3Pgr/Mmucd) 		seizures J:74249
Atp1a3Myk/Atp1a3+
(B6NCr.129S1-Atp1a3Myk) 		abnormal seizure response to inducing agent J:180250
abnormal spike wave discharge J:151948
convulsive seizures J:151948
environmentally induced seizures J:151948
Atp1a3Myk/Atp1a3+
(involves: 129S1/SvImJ * C57BL/6J * C57BL/6NCr) 		abnormal spike wave discharge J:151948
convulsive seizures J:151948
environmentally induced seizures J:151948
Atp1a3tm1.1Tmklh/Atp1a3+
(B6JRj.129S1-Atp1a3tm1.1Tmklh) 		increased susceptibility to pharmacologically induced seizures J:254463
Atp1a3tm1Mika/Atp1a3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal seizure response to inducing agent J:264408
increased kindling response J:264408
seizures J:264408
Atp1a3tm1Ute/Atp1a3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased kindling response J:262419
increased susceptibility to pharmacologically induced seizures J:262419
seizures J:262419
Atp6v1b2tm1Yoyu/Atp6v1b2tm1Yoyu
(involves: C57BL/6) 		environmentally induced seizures J:278514
Atp7aMo-ml/Y
(C3Hf/He) 		tonic seizures J:40664
Atrnmg-3J/Atrnmg-3J
(C3HeB/FeJ-Atrnmg-3J/J) 		seizures J:96070
Atxn7tm1Hzo/Atxn7+
(involves: 129S7/SvEvBrd * C57BL/6) 		myoclonus J:82072
Avpr1btm1Dgen/Avpr1btm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
B4galnt1tm1Rlp/B4galnt1tm1Rlp
St8sia1tm1Rlp/St8sia1tm1Rlp
(involves: 129S6/SvEvTac) 		audiogenic seizures J:67955
seizures J:67955
tonic-clonic seizures J:67955
Baiap3tm1Smwk/Baiap3tm1Smwk
(B6N.129P2-Baiap3tm1Smwk) 		increased susceptibility to pharmacologically induced seizures J:221234
Bak1tm1Thsn/Bak1tm1Thsn
Baxtm1Sjk/Baxtm1Sjk
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6) 		seizures J:66872
BckdkGt(VICT48)710Lex/BckdkGt(VICT48)710Lex
(B6.129S5/SvEvBrd-BckdkGt(VICT48)710Lex) 		seizures J:117564
tonic-clonic seizures J:117564
Bdnftm3Jae/Bdnftm3Jae
Tg(Syn1-cre)671Jxm/0
(involves: 129/Sv * C57BL/6 * ICR) 		abnormal kindling response J:91467
Bhlhe40tm1.1Rhli/Bhlhe40tm1.1Rhli
(involves: 129S1/Sv * C57BL/6 * CD-1 * SJL) 		increased susceptibility to pharmacologically induced seizures J:131834
Bidtm1Sjk/Bidtm1Sjk
Cstbtm1Rm/Cstbtm1Rm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		myoclonus J:115694
seizures J:115694
Bis1C57BL/6J/?
(involves: A/J * C57BL/6J) 		abnormal seizure response to pharmacological agent J:54925
Bis4A/J/?
(involves: A/J * C57BL/6J) 		abnormal seizure response to pharmacological agent J:54925
Bloc1s6pa/Bloc1s6pa
(B6.Cg-Bloc1s6pa/J) 		tonic seizures J:5215
Bmi1tm1Brn/Bmi1tm1Brn
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB)) 		sporadic seizures J:17712
Braftm1Bbd/Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CD-1) 		convulsive seizures J:170095
Bsntm1Gund/Bsntm1Gund
(Not Specified) 		clonic seizures J:82241
convulsive seizures J:82241
increased susceptibility to pharmacologically induced seizures J:82241
myoclonus J:82241
C1qatm1Mjw/C1qatm1Mjw
(involves: 129S/SvEv) 		absence seizures J:159281
seizures J:159281
Cacna1arkr/Cacna1arkr
(B6.Cg-Cacna1arkr) 		absence seizures J:71860
Cacna1atg-4J/Cacna1atg-4J
(B6.C3Bir-Cacna1atg-4J) 		absence seizures J:137816
Cacna1atg/Cacna1atg
(B6.D2-Cacna1atg/J) 		increased susceptibility to pharmacologically induced seizures J:6154
seizures J:6154
Cacna1atg/Cacna1atg
(involves: 101 * C3H * C57BL/10 * DBA/2J) 		seizures J:262
sporadic seizures J:262
Cacna1atm1.1Sher/Cacna1atm1.1Sher
Tg(Pcp2-cre)2Mpin/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		abnormal seizure response to inducing agent J:170451
abnormal spike wave discharge J:170451
absence seizures J:170451
environmentally induced seizures J:170451
Cacna1atm1.2Sher/Cacna1atm1.2Sher
(involves: 129S4/SvJae) 		seizures J:170451
Cacna1atm1Hssh/Cacna1atm1Hssh
(involves: C57BL/6J) 		abnormal spike wave discharge J:59076
Cacna1atm1Lory/Cacna1a+
(involves: C57BL/6 * C57BL/6J) 		absence seizures J:258570
Cacna1atm1Nobs/Cacna1atm2Nobs
(involves: 129 * C57BL/6J) 		absence seizures J:155607
Cacna1atm2Nobs/Cacna1atm2Nobs
(involves: 129 * C57BL/6J) 		abnormal spike wave discharge J:155607
absence seizures J:155607
clonic seizures J:155607
Cacna1atm3Maag/Cacna1atm3Maag
(B6.129P2-Cacna1atm3Maag) 		seizures J:144701
Cacna1gtm1Hssh/Cacna1gtm1Hssh
(involves: 129S4/SvJae * C57BL/6J) 		abnormal spike wave discharge J:70557
decreased susceptibility to pharmacologically induced seizures J:70557
Cacna2d2du-2J/Cacna2d2du-2J
(involves: C57BLKS/J-Cacna2d2du-2J/LetJ) 		abnormal spike wave discharge J:70845
absence seizures J:70845
Cacna2d2du-2J/Cacna2d2du-2J
(involves: C57BL/6 * C57BLKS/J) 		absence seizures J:213548
Cacna2d2du-3J/Cacna2d2du-3J
(involves: BALB/cByJ * C57BL/6J) 		myoclonus J:82238
Cacna2d2du/Cacna2d2du
(TKDU/DnJ) 		seizures J:5263
Cacna2d2du/Cacna2d2du
(TKDU) 		seizures J:152373
Cacna2d2ent/Cacna2d2ent
(either: B6.D2-Cacna2d2ent or (involves: C57BL/6J * CD-1 * DBA/2J)) 		seizures J:88967
Cacna2d2tm1Svi/Cacna2d2tm1Svi
(involves: 129S1/Sv * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:92396
myoclonus J:92396
seizures J:92396
tonic seizures J:92396
Cacnb4lh-2J/Cacnb4lh-2J
(involves: C3H * C57BL/6 * DBA/2J) 		seizures J:137891
Cacnb4lh/Cacnb4lh
(involves: BALB/cGn * C3H/HeSnJ * C57BL/6JEi) 		clonic seizures J:79139
seizures J:1484
tonic seizures J:79139
Cacnb4lh/Cacnb4lh
(involves: BALB/cGn) 		convulsive seizures J:28466
Cacng2stg-3J/Cacng2+
Cacng4tm1Frk/Cacng4+
(involves: B6C3-Cacng2stg-3J/J * B6.129-Cacng4tm1Frk/J) 		absence seizures J:96506
Cacng2stg-3J/Cacng2stg-3J
Cacng4tm1Frk/Cacng4+
(involves: B6C3-Cacng2stg-3J/J * B6.129-Cacng4tm1Frk/J) 		absence seizures J:96506
Cacng2stg-3J/Cacng2stg-3J
Cacng4tm1Frk/Cacng4tm1Frk
(involves: B6C3-Cacng2stg-3J/J * B6.129-Cacng4tm1Frk/J) 		absence seizures J:96506
Cacng2stg-wag/Cacng2stg-wag
(B6.MRL-Cacng2stg-wag/J) 		absence seizures J:96506
Cacng2stg-wag/Cacng2stg-wag
Cacng4tm1Frk/Cacng4tm1Frk
(involves: B6.MRL-Cacng2stg-wag/J * B6.129-Cacng4tm1Frk/J) 		absence seizures J:96506
Cacng2stg/Cacng2stg
(B6C3Fe a/a-Cacng2stg) 		absence seizures J:15527
Camk2atm1.1Oyam/Camk2a+
(either: B6.Cg-Camk2atm1.1Oyam or (involves: C57BL/6 * CBA * ICR)) 		sporadic seizures J:150046
Camk2atm1.1Oyam/Camk2atm1.1Oyam
(either: B6.Cg-Camk2atm1.1Oyam or (involves: C57BL/6 * CBA * ICR)) 		sporadic seizures J:150046
Camk2atm4Sva/Camk2atm4Sva
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac) 		seizures J:79714
Camk2atm5Sva/Camk2atm5Sva
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac) 		seizures J:79714
Car7tm1.1Kkai/Car7tm1.1Kkai
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		environmentally induced seizures J:200079
Ccm2tm2.1Sbn/Ccm2tm2.1Sbn
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		seizures J:174085
Cd3em1Btlr/Cd3em1Btlr
(C57BL/6J-Cd3em1Btlr) 		seizures J:132486
Cdk5r1tm1Lht/Cdk5r1tm1Lht
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:38857
seizures J:38857
Cdk5r1tm1Lht/Cdk5r1tm1Lht
(involves: 129S4/SvJae) 		seizures J:38857
Cdkl5tm1.2Cogr/Y
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6J) 		abnormal seizure response to inducing agent J:209635
seizures J:209635
Cdkl5tm1.2Cogr/Cdkl5tm1.2Cogr
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6J) 		abnormal seizure response to inducing agent J:209635
seizures J:209635
Cdkn1btm1Mlf/Cdkn1btm1Mlf
Cdkn2dtm1Maro/Cdkn2dtm1Maro
(involves: 129X1/SvJ * C57BL/6) 		seizures J:58522
Cdkn2atm1Nesh/Cdkn2atm1Nesh
(involves: 129S6/SvEvTac * FVB/N) 		seizures J:88365
Cdyltm1.1Yuw/Cdyltm1.1Yuw
Emx1tm1(cre)Yql/Emx1+
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:251551
Celf4Ff/Celf4+
(involves: C57BL/6J) 		abnormal seizure response to electrical stimulation J:123744
seizures J:123744
Celf4Ff/Celf4Ff
(involves: C57BL/6J) 		tonic-clonic seizures J:123744
Celf4Ff/Celf4Ff
(involves: C57BL/6J * FVB/NJ) 		absence seizures J:123744
Celf4tm1.1Frk/Celf4tm1.1Frk
Emx1tm1(cre)Krj/?
(involves: 129 * C57BL/6J) 		increased susceptibility to induction of seizure by inducing agent J:19671
Celf4tm1.1Frk/Celf4tm1.1Frk
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129 * C57BL/6J) 		abnormal spike wave discharge J:181678
convulsive seizures J:181678
Celf4tm1.1Frk/Celf4tm1.1Frk
Tg(Camk2a-cre)1Lfr/0
(involves: 129 * C57BL/6J) 		increased susceptibility to induction of seizure by inducing agent J:194671
Celf4tm1.1Frk/Celf4tm1.1Frk
Tg(Slc32a1-cre)2.1Hzo/0
(involves: 129 * C57BL/6J * FVB) 		decreased susceptibility to induction of seizure by inducing agent J:194671
Celf4tm1.2Frk/Celf4+
(129S1.129(Cg)-Celf4tm1.2Frk/Frk) 		tonic-clonic seizures J:181678
Celf4tm1.2Frk/Celf4tm1.2Frk
(129S1.129(Cg)-Celf4tm1.2Frk/Frk) 		abnormal spike wave discharge J:181678
absence seizures J:181678
seizures J:181678
tonic-clonic seizures J:181678
Celf4tm1.2Frk/Celf4tm1.2Frk
((B6.129(Cg)-Celf4tm1.2Frk/Frk x 129S1.129(Cg)-Celf4tm1.2Frk/Frk)F1) 		abnormal spike wave discharge J:181678
absence seizures J:181678
Celf4tm1.2Frk/Celf4tm1.2Frk
(B6.129(Cg)-Celf4tm1.2Frk/Frk) 		seizures J:181678
tonic-clonic seizures J:181678
Cers1to/Cers1to
(either: FVB/N or (involves: C3H * C57BL/6J * FVB/N)) 		seizures J:91243
Cfl1tm1.1Wit/Cfl1tm1.1Wit
(involves: 129 * C57BL/6 * SJL) 		seizures J:125317
cg/cg
(involves: C57BL/6Ga) 		tonic-clonic seizures J:11941
Chn1tm1.1Abet/Chn1tm1.1Abet
(involves: 129P2/OlaHsd * FVB/N) 		tonic seizures J:128724
Chn1tm2Abet/Chn1tm2Abet
(involves: 129P2/OlaHsd * FVB/N) 		tonic seizures J:128724
Chrna4tm1Dra/Chrna4tm1Dra
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:97020
Chrna4tm1Jbou/Chrna4+
(either: (involves: 129S4/SvJae * 129X1/SvJ * C57BL/6J) or (involves: 129X1/SvJ * C57BL/6J)) 		clonic seizures J:118273
seizures J:118273
Chrna4tm1Jbou/Chrna4tm1Jbou
(either: (involves: 129S4/SvJae * 129X1/SvJ * C57BL/6J) or (involves: 129X1/SvJ * C57BL/6J)) 		clonic seizures J:118273
seizures J:118273
Chrna4tm2Jbou/Chrna4+
(either: (involves: 129S4/SvJae * 129X1/SvJ * C57BL/6J) or (involves: 129X1/SvJ * C57BL/6J)) 		clonic seizures J:118273
seizures J:118273
Chrna4tm2Jbou/Chrna4tm2Jbou
(either: (involves: 129S4/SvJae * 129X1/SvJ * C57BL/6J) or (involves: 129X1/SvJ * C57BL/6J)) 		clonic seizures J:118273
seizures J:118273
Chrna5tm1Mdb/Chrna5tm1Mdb
(B6.129-Chrna5tm1Mdb) 		decreased susceptibility to pharmacologically induced seizures J:89266
Chrna5tm1Mdb/Chrna5tm1Mdb
Chrnb4tm1Mdb/Chrnb4tm1Mdb
(B6.129-Chrnb4tm1Mdb Chrna5tm1Mdb) 		decreased susceptibility to pharmacologically induced seizures J:89266
Chrna7tm1Bay/Chrna7tm1Bay
(B6.Cg-Chrna7tm1Bay) 		abnormal seizure response to pharmacological agent J:74703
Chrnb2tm1.1Cont/Chrnb2+
(B6.129-Chrnb2tm1.1Cont) 		increased susceptibility to induction of seizure by inducing agent J:228269
Chrnb2tm1.1Cont/Chrnb2tm1.1Cont
(B6.129-Chrnb2tm1.1Cont) 		increased susceptibility to induction of seizure by inducing agent J:228269
Chrnb4tm1Mdb/Chrnb4tm1Mdb
(B6.129-Chrnb4tm1Mdb) 		decreased susceptibility to pharmacologically induced seizures J:89266
Cittm1Fdc/Cittm1Fdc
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		increased susceptibility to pharmacologically induced seizures J:77297
myoclonus J:77297
Ckbtm1Bew/Ckbtm1Bew
(involves: 129P/Ola * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:89399
Clcn3tm1Lamb/Clcn3tm1Lamb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased susceptibility to pharmacologically induced seizures J:80901
seizures J:80901
tonic-clonic seizures J:80901
Clcn7tm1.1Lex/Clcn7tm1.1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		tonic seizures J:186049
Cln3tm1Blda/Cln3tm1Blda
(B6.129-Cln3tm1Blda) 		increased susceptibility to pharmacologically induced seizures J:125194
Cln6nclf/Cln6nclf
(involves: C57BL/6J * C57BL/10J * C3HeB/FeJLe) 		seizures J:47292
Cln8mnd/Cln8mnd
(involves: B6.KB2) 		seizures J:47292
Cnptm1(cre)Kan/Cnptm1(cre)Kan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		convulsive seizures J:91814
Cnr1tm1.1Ltz/Cnr1+
(involves: 129P2/OlaHsd * C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:89842
Cnr1tm1.1Ltz/Cnr1tm1.1Ltz
(involves: 129P2/OlaHsd * C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:89842
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz
(involves: 129P2/OlaHsd * C57BL/6NCrl) 		increased susceptibility to pharmacologically induced seizures J:122066
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz
Neurod6tm1(cre)Kan/Neurod6+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6NCrl) 		increased susceptibility to pharmacologically induced seizures J:122066
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz
Tg(Camk2a-cre)2Gsc/0
(involves: 129P2/OlaHsd * C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:89842
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz
Tg(Camk2a-cre)2Gsc/?
(involves: 129P2/OlaHsd * C57BL/6NCrl * FVB/N) 		increased susceptibility to pharmacologically induced seizures J:122066
Cnr1tm2Ltz/Cnr1tm2Ltz
(B6.Cg-Cnr1tm2Ltz) 		increased susceptibility to pharmacologically induced seizures J:199647
Cntn2tm1Fuka/Cntn2tm1Fuka
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:67556
sporadic seizures J:67556
Cntn5tm1Kwat/Cntn5tm1Kwat
(involves: 129X1/SvJ * C57BL/6J) 		audiogenic seizures J:89425
Cntnap2tm1Pele/Cntnap2tm1Pele
(B6.129-Cntnap2tm1Pele) 		environmentally induced seizures J:177110
seizures J:177110
Cntnap4tm1Pele/Cntnap4tm1Pele
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		seizures J:211338
Col1a1tm3(CAG-IDH2*R140Q)Kkw/Col1a1+
Tmem163Tg(ACTB-cre)2Mrt/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * FVB/N) 		seizures J:209629
Col2a1sedc/Col2a1sedc
(involves: C57BL/6J) 		seizures J:85735
Col4a1deltaex40/Col4a1+
(B6.129S-Col4a1deltaex40) 		seizures J:215446
Coq8atm1.1Ics/Coq8atm1.1Ics
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N) 		environmentally induced seizures J:249129
increased susceptibility to pharmacologically induced seizures J:249129
Cosz1DBA/2J/Cosz1DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:66464
Cosz2DBA/2J/Cosz2DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:66464
Cosz3C57BL/6J/Cosz3C57BL/6J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:66464
Cosz3C57BL/6J/Cosz3DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:66464
Cplx1tm1Rmnd/Cplx1tm1Rmnd
(Not Specified) 		sporadic seizures J:86365
CrebbpGt(U-San)112Imeg/Crebbp+
(involves: C57BL/6 * CBA) 		seizures J:53370
Cremtm1.1Endo/Cremtm1.1Endo
(C57BL/6-Cremtm1.1Endo) 		abnormal kindling response J:137666
cri/cri
(involves: DBA/2J) 		clonic seizures J:6110
Cstbtm1Rm/Cstbtm1Rm
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		myoclonus J:50587
Cstbtm1Rm/Cstbtm1Rm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		myoclonus J:115694
seizures J:115694
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Emx1tm1(cre)Yql/Emx1+
(B6.129-Emx1tm1(cre)Yql Ctnnb1tm2Kem) 		increased susceptibility to pharmacologically induced seizures J:92923
seizures J:92923
Ctsdtm1Cptr/Ctsdtm1Cptr
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd)) 		seizures J:71688, J:64892
tonic seizures J:64892
Cul4btm1Swl/Y
Edil3Tg(Sox2-cre)1Amc/Edil3+
(B6.Cg-Edil3Tg(Sox2-cre)1Amc Cul4btm1Swl) 		increased susceptibility to pharmacologically induced seizures J:187403
Dbnltm1Jwnd/Dbnl+
(involves: BALB/c) 		convulsive seizures J:109363
Dbptm1Schb/Dbptm1Schb
Hlftm1Schb/Hlftm1Schb
Teftm1Schb/Tef+
(involves: 129P2/OlaHsd * 129S2/SvPas) 		absence seizures J:90854
seizures J:90854
Dbptm1Schb/Dbptm1Schb
Hlftm1Schb/Hlftm1Schb
Teftm1Schb/Teftm1Schb
(involves: 129P2/OlaHsd * 129S2/SvPas) 		absence seizures J:90854
audiogenic seizures J:90854
seizures J:90854
tonic-clonic seizures J:90854
Dclk2tm1.2Jgg/Dclk2tm1.2Jgg
Dcxtm1Caw/Y
(involves: 129/Sv * C57BL/6) 		convulsive seizures J:148345
tonic-clonic seizures J:148345
Dclk2tm1.2Jgg/Dclk2tm1.2Jgg
Dcxtm1Caw/Dcxtm1Caw
(involves: 129/Sv * C57BL/6) 		convulsive seizures J:148345
tonic-clonic seizures J:148345
Del(5D5Mit73-D5Mit351)5Jcs/+
(involves: 129S4/SvJae * C57BL/6J) 		maximal tonic hindlimb extension seizures J:67077
seizures J:67077
Del(5D5Mit388-D5Mit351)4Jcs/+
(involves: 129S4/SvJae * C57BL/6J) 		abnormal seizure response to electrical stimulation J:67077
Del(5Letm1-D5Mit81)3Jcs/+
(involves: 129S4/SvJae * C57BL/6J) 		abnormal seizure response to electrical stimulation J:67077
Del(5Letm1-Htt)1Jcs/+
(involves: 129S4/SvJae * C57BL/6J) 		convulsive seizures J:67077
Del(7Chrna7-Fan1)3Arte/+
(involves: C57BL/6J * C57BL/6NTac) 		abnormal seizure response to electrical stimulation J:260165
abnormal seizure response to pharmacological agent J:260165
decreased susceptibility to pharmacologically induced seizures J:260165
Del(7Gabrb3-Ube3a)1Yhj/+
(B6.129S7-Del(7Gabrb3-Ube3a)1Yhj) 		tonic-clonic seizures J:164010
Del(11Cops3-Rnf112)1Jrl/+
(involves: 129S7/SvEvBrd * C57BL/6) 		seizures J:88027
tonic-clonic seizures J:83302
Del(XArmcx5-Nxf3)3Jw/+
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		environmentally induced seizures J:210663
Del(XNxf2-Nxf3)1Jw/+
(involves: 129S4/SvJae * C57BL/6 * FVB) 		audiogenic seizures J:210663
environmentally induced seizures J:210663
sporadic seizures J:210663
Depdc5tm1c(EUCOMM)Hmgu/Depdc5tm1c(EUCOMM)Hmgu
Tg(Syn1-cre)671Jxm/0
(involves: C57BL/6N * CBA) 		increased susceptibility to pharmacologically induced seizures J:260943
seizures J:260943
tonic seizures J:260943
tonic-clonic seizures J:260943
DgkdGt(RRT600)Byg/DgkdGt(RRT600)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:126380
Dgketm1Ngb/Dgketm1Ngb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		tonic seizures J:68824
Dmtf1tm1Cjs/Dmtf1tm1Cjs
(involves: 129/Sv * C57BL/6) 		seizures J:63444
Dnm1Ftfl/Dnm1+
(C57BL/6J-Dnm1Ftfl) 		abnormal kindling response J:163311
abnormal seizure response to electrical stimulation J:163311
tonic seizures J:163311
Dnm1Ftfl/Dnm1+
(FVB.B6-Dnm1Ftfl/Frk) 		seizures J:235711
Dnm1Ftfl/Dnm1Ftfl
(C57BL/6J-Dnm1Ftfl) 		convulsive seizures J:163311
tonic-clonic seizures J:163311
Dnm1Ftfl/Dnm1tm1.2Frk
(involves: 129 * C57BL/6J * FVB) 		seizures J:235711
Dnm1Ftfl/Dnm1tm2.2Frk
(involves: 129 * C57BL/6J * FVB) 		seizures J:235711
Drd1tm2Jcd/Drd1+
Tg(Camk2a-cre)2Gsc/0
(involves: 129S4/SvJae * FVB/N) 		seizures J:120070
Drd1tm2Jcd/Drd1+
Tg(EIIa-cre)C5379Lmgd/0
(involves: 129S4/SvJae * BALB/c * CD-1 * FVB/N) 		myoclonus J:120582
Drd2tm1Ebo/Drd2tm1Ebo
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:65767
Dscamdel17/Dscamdel17
(involves: BALB/cByJ * C57BL/6J) 		seizures J:129238
Dstdt-33J/Dstdt-33J
(129S1/Sv) 		seizures J:61053
Ecpasem1Plch/Ecpasem1Plch
(C57BL/6-Ecpasem1Plch) 		increased susceptibility to pharmacologically induced seizures J:282974
Efhc1tm1Kzy/Efhc1+
(B6.129P2-Efhc1tm1Kzy) 		increased susceptibility to pharmacologically induced seizures J:145858
myoclonus J:145858
Efhc1tm1Kzy/Efhc1tm1Kzy
(B6.129P2-Efhc1tm1Kzy) 		increased susceptibility to pharmacologically induced seizures J:145858
myoclonus J:145858
Eif2ak3tm1Dron/Eif2ak3+
Tg(GFAP-tTA)110Pop/0
Tg(tetO-Ifng)184Pop/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2 * Swiss Webster) 		tonic seizures J:99655
Eif2b4tm1.1Vdk/Eif2b4+
Eif2b5tm1.1Vdk/Eif2b5tm1.1Vdk
(involves: C57BL/6 * C57BL/6J) 		sporadic seizures J:234659
Eif2b4tm1.1Vdk/Eif2b4tm1.1Vdk
(involves: C57BL/6 * C57BL/6J) 		sporadic seizures J:234659
Eif2b4tm1.1Vdk/Eif2b4tm1.1Vdk
Eif2b5tm1.1Vdk/Eif2b5+
(involves: C57BL/6 * C57BL/6J) 		sporadic seizures J:234659
Eif2b4tm1.1Vdk/Eif2b4tm1.1Vdk
Eif2b5tm1.1Vdk/Eif2b5tm1.1Vdk
(involves: C57BL/6 * C57BL/6J) 		sporadic seizures J:234659
Eif2b5tm1.1Vdk/Eif2b5tm1.1Vdk
(involves: C57BL/6 * C57BL/6J) 		sporadic seizures J:234659
El1EL/?
(involves: DBA/2J * EL) 		seizures J:11381
El1EL/?
(involves: ABP/LeJ * EL) 		seizures J:11381
El2EL/?
(involves: ABP/LeJ * EL) 		seizures J:11381
El2EL/El2EL
(involves: ABP/LeJ * EL/Suz) 		seizures J:114157
El3EL/SuzSeyFrkJ/El3ABP/LeJ
(involves: ABP/LeJ * EL/Suz) 		seizures J:30433
El3EL/SuzSeyFrkJ/El3EL/SuzSeyFrkJ
(involves: ABP/LeJ * EL/Suz) 		seizures J:30433
El4EL/SuzSeyFrkJ/El4EL/SuzSeyFrkJ
(involves: DDY/Jcl * EL/Suz) 		seizures J:30433
El4EL/SuzSeyFrkJ/El4EL/SuzSeyFrkJ
(involves: ABP/LeJ * EL/Suz) 		seizures J:30433, J:114157
El5DDY/Jcl/El5EL/SuzSeyFrkJ
(involves: DDY/Jcl * EL/Suz) 		seizures J:30433
El5EL/SuzSeyFrkJ/El5EL/SuzSeyFrkJ
(involves: DDY/Jcl * EL/Suz) 		seizures J:30433
El6DDY/Jcl/El6DDY/Jcl
(involves: DDY/Jcl * EL/Suz) 		seizures J:30433
Elavl3tm1.1Rbd/Elavl3+
(either: (involves: 129 * C57BL/6) or (involves: 129 * CD-1)) 		abnormal spike wave discharge J:188326
Elavl3tm1.1Rbd/Elavl3tm1.1Rbd
(either: (involves: 129 * C57BL/6) or (involves: 129 * CD-1)) 		abnormal spike wave discharge J:188326
nonconvulsive seizures J:188326
Elfn1tm1(KOMP)Vlcg/Elfn1tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		seizures J:209758
Elfn1tm1.1Jaru/Elfn1tm1.1Jaru
(involves: C57BL/6) 		environmentally induced seizures J:226212
increased susceptibility to pharmacologically induced seizures J:226212
Elfn2tm1(KOMP)Vlcg/Elfn2tm1(KOMP)Vlcg
(C57BL/6NTac-Elfn2tm1(KOMP)Vlcg) 		audiogenic seizures J:286127
increased susceptibility to pharmacologically induced seizures J:286127
ElnvEL/SuzSeyFrkJ/ElnvEL/SuzSeyFrkJ
(involves: ABP/LeJ * EL/Suz) 		seizures J:114157
Elovl4tm1Wked/Elovl4tm1Wked
Tg(IVL-Elovl4)#Wked/0
Tg(KRT14-Elovl4)#Mpag/0
(involves: 129 * C57BL/6) 		seizures J:277065
Elp1tm1Id/Elp1tm1.1Id
Tg(Hsp70-1-cre)6Arge/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA) 		audiogenic seizures J:188923
environmentally induced seizures J:188923
Elp1tm1Id/Elp1tm1Id
Tg(Hsp70-1-cre)6Arge/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA) 		audiogenic seizures J:188923
environmentally induced seizures J:188923
Eml1heco/Eml1heco
(involves: NOR) 		increased susceptibility to pharmacologically induced seizures J:208031
myoclonus J:208031
seizures J:208031
Emx1tm1(cre)Krj/?
Kcnq2tm1.1Avtz/Kcnq2tm1.1Avtz
(involves: 129S2/SvPas * C57BL/6) 		tonic-clonic seizures J:208109
Emx1tm1(cre)Krj/Emx1+
Numbtm1Ynj/Numbtm1Ynj
Numbltm1Wmz/Numbltm1Wmz
(involves: 129S2/SvPas * 129X1/SvJ * CD-1) 		sporadic seizures J:87149
Emx1tm1.1(cre)Ito/Emx1+
Scn1atm2.1Kzy/Scn1atm2.1Kzy
Tg(Slc32a1-cre)65Kzy/0
(involves: 129P2/OlaHsd * C57BL/6) 		convulsive seizures J:202863
Emx1tm1.1(cre)Ito/Emx1+
Tg(Gfap-GFAP*R239H)60TMIke/0
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:139349
epf/epf
(Not Specified) 		seizures J:6309
Epm2atm1Kzy/Epm2atm1Kzy
(involves: 129P2/OlaHsd * C57BL/6J) 		myoclonus J:76688
Ercc6tm1Gvh/Ercc6tm1Gvh
Xpatm1Gvh/Xpatm1Hvs
Tg(Camk2a-cre)1Szi/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA) 		seizures J:179808
Exq1A/J/?
(involves: A/J * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:54925
Exq1C57BL/6J/?
(involves: A/J * C57BL/6J) 		abnormal seizure response to pharmacological agent J:54925
Faim2tm1Dgen/Faim2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Fcgr2btm1Ttk/Fcgr2btm1Ttk
(B6.129S4-Fcgr2btm1Ttk) 		abnormal seizure response to electrical stimulation J:169028
maximal tonic hindlimb extension seizures J:169028
tonic-clonic seizures J:169028
Fgf7tm1Efu/Fgf7tm1Efu
(B6.129-Fgf7tm1Efu) 		increased susceptibility to pharmacologically induced seizures J:161954
Fgf13tm1Jom/Fgf13+
(C57BL/6-Fgf13tm1Jom) 		abnormal kindling response J:222555
environmentally induced seizures J:222555
seizures J:222555
Fgf14tm1Dor/Fgf14tm1Dor
(129S6/SvEvTac-Fgf14tm1Dor) 		increased susceptibility to pharmacologically induced seizures J:77806
Fgf14tm1Dor/Fgf14tm1Dor
(B6.129S6-Fgf14tm1Dor) 		increased susceptibility to pharmacologically induced seizures J:77806
Fgf22tm1Dgen/Fgf22tm1Dgen
(B6.Cg-Fgf22tm1Dgen) 		decreased susceptibility to pharmacologically induced seizures J:161954
Fmr1tm1Cgr/Y
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		audiogenic seizures J:127792
Fmr1tm1Cgr/Y
(involves: 129P2/OlaHsd * FVB) 		convulsive seizures J:113177
tonic-clonic seizures J:113177
Fmr1tm1Cgr/Y
(either: FVB.129P2(B6)-Fmr1tm1Cgr/J or FVB;129P2(B6)-Fmr1tm1Cgr/J) 		audiogenic seizures J:85912
Fmr1tm1Cgr/Y
Grm5tm1Rod/Grm5+
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		audiogenic seizures J:127792
Fmr1tm1Rbd/Y
(B6.129-Fmr1tm1Rbd) 		audiogenic seizures J:155593
Fosbtm1Brv/Fosbtm1Brv
(involves: 129S2/SvPas) 		tonic-clonic seizures J:33415
Fosbtm1Meg/Fosbtm1Meg
(involves: 129S4/SvJae * 129X1/SvJ) 		abnormal seizure response to electrical stimulation J:110995
Foxa2tm1Khk/Foxa2tm1Khk
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA) 		seizures J:70409
Fyntm1Sor/Fyn+
Tg(Camk2a-Fyn-531)1Nko/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA) 		tonic seizures J:59490
Fyntm1Yik/Fyntm1Yik
(involves: C57BL/6 * CBA) 		audiogenic seizures J:23384
Fzd9tm1Sjp/Fzd9tm1Sjp
(involves: C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:99893
G6pctm1Jyc/G6pctm1Jyc
(involves: 129S4/SvJae) 		seizures J:33212
G6pctm2.2Jyc/G6pctm2.2Jyc
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J * FVB/N) 		seizures J:155990
Gabbr1tm1Bet/Gabbr1tm1Bet
(BALB/c-Gabbr1tm1Bet) 		absence seizures J:70558
audiogenic seizures J:70558
clonic seizures J:70558
seizures J:70558
tonic-clonic seizures J:70558
Gabbr1tm1Pngl/Gabbr1tm1Pngl
(involves: 129P2/OlaHsd * C57BL/6J) 		sporadic seizures J:70254
tonic-clonic seizures J:70254
Gabbr2tm1Arca/Gabbr2tm1Arca
(involves: 129P2/OlaHsd) 		seizures J:146953
tonic-clonic seizures J:146953
Gabbr2tm1Bet/Gabbr2tm1Bet
(BALB/c-Gabbr2tm1Bet) 		clonic seizures J:103989
Gabra1tm1.1Geh/Gabra1+
(D2.129(Cg)-Gabra1tm1.1Geh) 		abnormal spike wave discharge J:186685
absence seizures J:186685
Gabra1tm1.1Geh/Gabra1+
(B6.129(Cg)-Gabra1tm1.1Geh) 		abnormal spike wave discharge J:227437, J:186685
absence seizures J:227437, J:186685
increased susceptibility to pharmacologically induced seizures J:227437
myoclonus J:227437
seizures J:227437
tonic-clonic seizures J:227437
Gabra1tm1.1Mjga/Gabra1+
(B6J.Cg-Gabra1tm1.1Mjga) 		abnormal spike wave discharge J:227437
absence seizures J:227437
increased susceptibility to pharmacologically induced seizures J:227437
myoclonus J:227437
seizures J:227437
tonic-clonic seizures J:227437
Gabra1tm1.1Uru/Gabra1tm1.1Uru
(either: 129X1.129P2-Gabra1tm1.1Uru or B6.129P2-Gabra1tm1.1Uru) 		increased susceptibility to pharmacologically induced seizures J:75895
Gabrb3tm1Geh/Gabrb3tm1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		seizures J:39801
Gabrb3tm2.1Geh/Gabrb3tm2.1Geh
Tg(Camk2a-cre)T29-1Stl/?
(involves: 129 * BALB/c * C57BL/6 * SJL) 		absence seizures J:127877
Gabrb3tm2.1Uru/Gabrb3tm2.1Uru
(B6J.129S6(Cg)-Gabrb3tm2.1Uru) 		increased susceptibility to pharmacologically induced seizures J:228332
Gabrdtm1.1Jmag/Gabrd+
Gad2tm2(cre)Zjh/Gad2+
(involves: 129S4/SvJae * C57BL/6 * SJL) 		decreased susceptibility to pharmacologically induced seizures J:203336
Gabrdtm1Geh/Gabrdtm1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		absence seizures J:64288
Gabrg2tm1Spet/Gabrg2+
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6) 		absence seizures J:127120
increased susceptibility to pharmacologically induced seizures J:127120
Gabrg2tm1Spet/Gabrg2+
(involves: 129 * BALB/cJ * C57BL/6 * DBA/2J) 		absence seizures J:127120
Gabrg2tm1Spet/Gabrg2+
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ) 		increased susceptibility to pharmacologically induced seizures J:194736
Gabrg2tm2Lusc/Gabrg2tm2Lusc
Tg(Camk2a-cre)2834Lusc/0
(involves: 129P2/OlaHsd * 129X1/SvJ) 		seizures J:86221
Gabrg2tm2Spet/Gabrg2+
(involves: 129S1/Sv * 129X1/SvJ) 		decreased susceptibility to pharmacologically induced seizures J:194196
Gabrg2tm2Spet/Gabrg2+
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-cre)LC1Bjd/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:194736
Gad2tm1Bae/Gad2tm1Bae
(involves: 129X1/SvJ * C57BL/6) 		seizures J:44638
Gad2tm1Bae/Gad2tm1Bae
(involves: 129X1/SvJ * NOD) 		seizures J:44638
Gad2tm1Miya/Gad2tm1Miya
(NOD.129P2-Gad2tm1Miya) 		seizures J:88785
Gad2tm1Oba/Gad2+
(involves: C57BL/6 * CBA) 		seizures J:37576
Gad2tm1Oba/Gad2tm1Oba
(involves: C57BL/6 * CBA) 		myoclonus J:62320
seizures J:62320, J:37576
tonic-clonic seizures J:62320
Galtm1Wyn/Galtm1Wyn
(129P2-Galtm1Wyn) 		increased susceptibility to pharmacologically induced seizures J:77625
seizures J:77625
Galctwi/Galctwi
Glb1tm1Adz/Glb1+
(involves: 129P2/OlaHsd * C57BL/6J * CE/J) 		seizures J:63197
Gantm1Yany/Gantm1Yany
(Not Specified) 		seizures J:108239
Gbatm1Karl/Gbatm1Karl
Tg(Nes-cre)1Kln/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		seizures J:127108
Gbatm2Karl/Gbatm2Karl
Tg(KRT14-cre)8Brn/?
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		seizures J:127108
Gdi1tm1Ytk/Gdi1tm1Ytk
(either: (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * C57BL/6 * DBA/2)) 		increased susceptibility to pharmacologically induced seizures J:65258
Gfaptm2Mes/Gfap+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * FVB/N) 		increased susceptibility to pharmacologically induced seizures J:114689
Gfaptm2Mes/Gfap+
Tg(GFAP)10Mes/0
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * FVB/N) 		seizures J:114689
Gfra2tm1Msa/Gfra2tm1Msa
(either: (involves: 129S1/Sv * 129S2/SvHsd * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6NHsd)) 		reduced kindling response J:53284
Gjb1tm1Kwi/Y
Gjc2tm1(EGFP)Kwi/Gjc2tm1(EGFP)Kwi
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		tonic seizures J:219594
Gjc2tm1(EGFP)Kwi/Gjc2tm1(EGFP)Kwi
Gjb1tm1Kwi/Gjb1tm1Kwi
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		seizures J:83885
sporadic seizures J:83885
tonic seizures J:83885, J:219594
Gjc2tm1Paul/Gjc2tm1Paul
Gjb1tm1Kwi/Gjb1tm1Kwi
(involves: 129/Sv * C57BL/6) 		tonic seizures J:84338
Glra1nmf11/Glra1nmf11
(C57BL/6J-Glra1nmf11/J) 		seizures J:78134
Glra1spd-ot9J/Glra1spd-ot9J
(B6.Cg-Glra1spd-ot9J/GrsrJ) 		tonic-clonic seizures J:234690
Glra1tm1.1Geh/Glra1tm1.1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL) 		increased susceptibility to pharmacologically induced seizures J:177105
Glra1tm1Rah/Glra1tm1Rah
(involves: 129X1/SvJ * C57BL/6J) 		seizures J:85341
Glra1tm2.1Geh/Glra1tm2.1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL) 		increased susceptibility to pharmacologically induced seizures J:177106
Glra3tm1Dgen/Glra3tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Glultm1.1Ncd/Glultm1.1Ncd
Emx1tm1(cre)Krj/Emx1+
(B6.Cg-Glultm1.1Ncd Emx1tm1(cre)Krj) 		seizures J:272643
Gna11tm1Soff/Gna11tm1Soff
Gnaqtm2Soff/Gnaqtm2Soff
Tg(Camk2a-cre)1Gsc/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * FVB/N) 		clonic seizures J:111559
seizures J:111559
tonic-clonic seizures J:111559
Gnao1em1Rneu/Gnao1+
(involves: C57BL/6J * C57BL/6NCrl) 		increased kindling response J:271137
Gnao1tm1Ejne/Gnao1tm1Ejne
(involves: 129S4/SvJae * C57BL/6) 		sporadic seizures J:39013
Gnao1tm2.1Rneu/Gnao1+
(B6.129S-Gnao1tm2.1Rneu) 		abnormal kindling response J:216850
Gnao1tm2Rneu/Gnao1+
(involves: 129S1/Sv * C57BL/6J) 		abnormal spike wave discharge J:197965
Gnb5flr/Gnb5flr
Myo5aflr/Myo5aflr
(involves: C57BL/6J * C57BL/10J * CBA/Ca) 		convulsive seizures J:61324
Gng3tm1.1Rbs/Gng3tm1.1Rbs
(involves: FVB/N) 		audiogenic seizures J:92791
convulsive seizures J:92791
Gng3tm1.1Rbs/Gng3tm1.1Rbs
(involves: C57BL/6J * FVB/N) 		audiogenic seizures J:92791
Gng3tm1.1Rbs/Gng3tm1.1Rbs
Gng7tm1Lex/Gng7tm1Lex
(B6.Cg-Gng7tm1Lex Gng3tm1.1Rbs) 		environmentally induced seizures J:182775
seizures J:182775
tonic-clonic seizures J:182775
Gpx4tm2Marc/Gpx4tm2Marc
Tg(Camk2a-cre)2Gsc/0
(involves: 129S2/SvPas * FVB/N) 		convulsive seizures J:139668
Gria2tm1Rsp/Gria2+
(involves: 129S1/Sv * 129X1/SvJ) 		seizures J:30145
tonic-clonic seizures J:30145
Gria2tm2.1Rsp/Gria2+
(involves: 129S1/Sv * 129X1/SvJ) 		seizures J:51845
Gria2tm2Rsp/Gria2+
Tg(Camk2a-cre)1Gsc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		seizures J:111689
Gria2tm2Rsp/Gria2+
Tg(Gria2*586N)238.2Rsp/0
(involves: 129S1/Sv * 129X1/SvJ) 		seizures J:51845
Gria3tm1Dgen/Y
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:101679
Gria3tm1Dgen/Gria3tm1Dgen
Gria4spkw1/Gria4spkw1
(involves: 129P2/OlaHsd * C3H/HeJ * C57BL/6J) 		absence seizures J:135814
Gria4spkw1/Gria4+
(involves: C3H/HeJ * C3HeB/FeJ) 		absence seizures J:135814
Gria4spkw1/Gria4spkw1
(involves: C3H/HeJ * C57BL/6J) 		absence seizures J:98638
Gria4spkw1/Gria4spkw1
(C3H/HeJ) 		absence seizures J:135814
Gria4spkw1/Gria4spkw1
(involves: C3H/HeJ * C3HeB/FeJ) 		absence seizures J:135814
Gria4spkw1/Gria4spkw1
(C3Fe.C3-Gria4spkw1) 		abnormal spike wave discharge J:228536
Gria4spkw1/Gria4spkw1
Pcnx2em1Frk/Pcnx2em1Frk
(C3Fe.C3-Pcnx2em1Frk Gria4spkw1) 		abnormal spike wave discharge J:228536
Gria4spkw1/Gria4spkw1
Pcnx2em5Frk/Pcnx2em5Frk
(C3Fe.C3-Pcnx2em5Frk Gria4spkw1) 		abnormal spike wave discharge J:228536
Gria4spkw1/Gria4spkw1
spkw2C3H/HeJ/spkw2C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		absence seizures J:98638
Gria4spkw1/Gria4tm1Dgen
(involves: 129P2/OlaHsd * C3H/HeJ * C57BL/6J) 		absence seizures J:135814
Gria4tm1Dgen/Gria4+
(involves: 129P2/OlaHsd * C57BL/6J) 		absence seizures J:135814
Gria4tm1Dgen/Gria4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal seizure response to pharmacological agent J:101679
Gria4tm1Dgen/Gria4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		absence seizures J:135814
Grik2tm1Bvis/Grik2tm1Bvis
(129S/Sv-Grik2tm1Bvis) 		increased susceptibility to pharmacologically induced seizures J:107698
Grik2tm1Sfh/Grik2tm1Sfh
(involves: 129S1/Sv * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:46932
Grik4tm1(cre)Mim/Grik4+
Grin1tm1Mim/Grin1tm1Mim
(involves: C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:144994
tonic-clonic seizures J:144994
Grik5tm1Dgen/Grik5tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Grin1tm1Blt/Grin1tm1Blt
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:62289
Grin2atm1Rsp/Grin2atm1Rsp
(involves: 129S1/Sv * 129X1/SvJ) 		reduced kindling response J:45446
Grm5tm1Dgen/Grm5tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased susceptibility to pharmacologically induced seizures J:82809
increased susceptibility to pharmacologically induced seizures J:82809
Grm7m1Btlr/Grm7m1Btlr
(C57BL/6J-Grm7m1Btlr) 		convulsive seizures J:224658
Grm7tm1Betz/Grm7tm1Betz
(B6.129P2-Grm7tm1Betz) 		increased susceptibility to pharmacologically induced seizures J:138831
Grm7tm1Dgen/Grm7tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Grm7tm1Nak/Grm7tm1Nak
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:52411
Gt(ROSA)26Sortm1(CAG-Bgeo,-Insc/GFP)Jakn/Gt(ROSA)26Sortm1(CAG-Bgeo,-Insc/GFP)Jakn
Tg(Nes-cre)1Wmz/0
(involves: C57BL/6) 		seizures J:178712
Gt(ROSA)26Sortm1(Crh)Jde/Gt(ROSA)26Sortm1(Crh)Jde
Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * C57BL/6 * SJL) 		abnormal seizure response to pharmacological agent J:140968
Gt(ROSA)26Sortm1(DTA)Jpmb/Gt(ROSA)26Sor+
Tg(Plp1-cre/ERT)3Pop/0
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		seizures J:234435
Gt(ROSA)26Sortm1.1(DUX4*)Plj/Gt(ROSA)26Sor+
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * C57BL/6) 		seizures J:256652
hael/hael
(C3.Cg-H2p hael/GrsrJ) 		tonic seizures J:231653
Hc1/Hc1
Tg(APPswe,PSEN1dE9)85Dbo/0
(D2.Cg-Tg(APPswe,PSEN1dE9)85Dbo) 		convulsive seizures J:227541
Hcn2ap/Hcn2+
(DW/Pas-Hcn2ap) 		abnormal spike wave discharge J:146530
absence seizures J:146530
increased susceptibility to pharmacologically induced seizures J:146530
Hcn2ap/Hcn2ap
(DW/Pas-Hcn2ap) 		abnormal spike wave discharge J:146530
absence seizures J:146530
tonic-clonic seizures J:146530
Hcn2tm1Ldw/Hcn2tm1Ldw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		absence seizures J:81398
Hcrtr1tm1Dgen/Hcrtr1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Hdac4Gt(OST361114)Lex/Hdac4Gt(OST361114)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		abnormal spike wave discharge J:152466
convulsive seizures J:152466
environmentally induced seizures J:152466
tonic seizures J:152466
Helttm1Wrst/Helttm1Wrst
(B6.Cg-Helttm1Wrst) 		seizures J:119562
tonic-clonic seizures J:119562
Hexatm1Grv/Hexatm1Grv
(involves: 129P2/Ola * C57BL/6J) 		convulsive seizures J:88460
Hexatm1Rlp/Hexatm1Rlp
Hexbtm1Rlp/Hexbtm1Rlp
(involves: 129S4/SvJae * C57BL/6) 		sporadic seizures J:36305
Hexbtm1Grv/Hexbtm1Grv
(either: (involves: 129P2/Ola * C57BL/6J) or (involves: 129S1/Sv * 129X1/SvJ * C57L/6J)) 		abnormal seizure response to electrical stimulation J:30899
hpc/hpc
(involves: STOCK Hps6ru f) 		clonic seizures J:64096
Hprttm1(CAG-Glra3*)Jcme/Y
Tg(Camk2a-cre)2Gsc/0
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N) 		increased susceptibility to pharmacologically induced seizures J:207981
Hprttm1Detl/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		convulsive seizures J:44728
seizures J:44728
Hprttm1Detl/Hprttm1Detl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		convulsive seizures J:44728
seizures J:44728
Hprttm2Detl/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:84451
Hprttm2Detl/Hprttm2Detl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:84451
Hprttm4Detl/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:84451
Hprttm4Detl/Hprttm4Detl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:84451
Hprttm6Detl/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:84451
Hprttm6Detl/Hprttm6Detl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:84451
Hrh2tm1Yfks/Hrh2tm1Yfks
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal seizure response to electrical stimulation J:102252
Htr1atm1Toth/Htr1atm1Toth
(involves: 129P2/OlaHsd * Black Swiss) 		increased susceptibility to pharmacologically induced seizures J:66581
Htr2ctm1Jke/Y
(B6.129-Htr2ctm1Jke) 		tonic-clonic seizures J:147514
Htr2ctm1Jke/Y
Tg(Pomc1-cre)16Lowl/0
(B6.Cg-Htr2ctm1Jke Tg(Pomc1-cre)16Lowl) 		tonic-clonic seizures J:147514
Htr2ctm1Jul/Y
(either: (involves: 129S2/SvPas * C57BL/6J * DBA/2) or (involves: 129S4/SvJae * C57BL/6J * DBA/2)) 		increased susceptibility to pharmacologically induced seizures J:24339
sporadic seizures J:24339
tonic seizures J:24339
tonic-clonic seizures J:24339
Htr2ctm2Jke/Y
Tg(Zp3-cre)93Knw/0
(involves: 129X1/SvJ * C57BL/6J) 		seizures J:207704
Htr4tm1Comp/Htr4tm1Comp
(129/Sv-Htr4tm1Comp) 		increased susceptibility to pharmacologically induced seizures J:87451
Htr7tm1Wtkn/Htr7tm1Wtkn
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		abnormal seizure response to electrical stimulation J:124549
increased susceptibility to pharmacologically induced seizures J:124549
Htra2mnd2/Htra2mnd2
(involves: C3H/HeJ * C57BL/6J * CAST/Ei) 		seizures J:50420
Htttm1Detl/Htttm1Detl
(involves: 129P2/OlaHsd * C57BL/6J) 		tonic-clonic seizures J:67074
Htttm2Detl/Htttm2Detl
(involves: 129P2/OlaHsd * C57BL/6J) 		tonic-clonic seizures J:123681, J:67074
Htttm6Mem/Htttm8Mem
(involves: 129S1/Sv * 129X1/SvJ * Swiss Webster) 		seizures J:72915
Igsf9tm1Kln/Igsf9tm1Kln
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:209586
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6J * CE/J) 		seizures J:63197
Impa1tm1Lex/Impa1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:157887
Iqsec2em1Csbg/Y
(C57BL/6NHsd-Iqsec2em1Csbg) 		sporadic seizures J:284750
Iqsec2em1Csbg/Iqsec2+
(C57BL/6NHsd-Iqsec2em1Csbg) 		sporadic seizures J:284750
Iqsec2em1Frk/Y
(involves: C3HeB/FeJ * C57BL/6NJ) 		convulsive seizures J:284762
decreased susceptibility to induction of seizure by inducing agent J:284762
decreased susceptibility to pharmacologically induced seizures J:284762
Iqsec2em1Frk/Iqsec2+
(involves: C3HeB/FeJ * C57BL/6NJ) 		decreased susceptibility to induction of seizure by inducing agent J:284762
Itgavtm2Hyn/Itgavtm2.1Hyn
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB * SJL) 		convulsive seizures J:94376
seizures J:94376
Itpr1opt/Itpr1opt
(involves: C57BLKS) 		seizures J:28829, J:37547, J:50383
Itpr1tm1Tno/Itpr1tm1Tno
(involves: 129S4/SvJae * C57BL/6) 		seizures J:30633
tonic-clonic seizures J:30633
jb/jb
(involves: C3HeB/FeJ * C57BL/6J) 		convulsive seizures J:39707
Juntm2.1Wag/Juntm2.1Wag
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		decreased susceptibility to pharmacologically induced seizures J:53481
Kcna1mceph/Kcna1mceph
(BALB/cByJ-Kcna1mceph/J) 		convulsive seizures J:89910, J:119491
seizures J:89910
tonic-clonic seizures J:89910
Kcna1tm1Tem/Kcna1+
(involves: 129S7/SvEvBrd * various) 		increased susceptibility to pharmacologically induced seizures J:47349
Kcna1tm1Tem/Kcna1tm1Tem
(involves: 129S7/SvEvBrd * various) 		increased susceptibility to pharmacologically induced seizures J:47349
seizures J:47349
tonic-clonic seizures J:47349
Kcna1tm1Tem/Kcna1tm1Tem
(C3Fe.129S7-Kcna1tm1Tem) 		seizures J:206598
Kcna1tm1Tem/Kcna1tm1Tem
(involves: 129S7/SvEvBrd * C57BL/6) 		seizures J:77281
Kcna1tm1Tem/Kcna1tm1Tem
(involves: 129S7SvEvBrd * BALB/cByJ * C3HeB/FeJ) 		convulsive seizures J:119491
Kcna1tm1Tem/Kcna1tm1Tem
(involves: 129S7/SvEvBrd) 		myoclonus J:164091
seizures J:164091
tonic-clonic seizures J:164091
Kcna2tm1Tem/Kcna2+
(C3Fe.129S7-Kcna2tm1Tem) 		increased susceptibility to pharmacologically induced seizures J:131735
Kcna2tm1Tem/Kcna2tm1Tem
(involves: 129S7/SvEvBrd * C57BL/6) 		tonic seizures J:131735
Kcna2tm1Tem/Kcna2tm1Tem
(C3Fe.129S7-Kcna2tm1Tem) 		increased susceptibility to pharmacologically induced seizures J:131735
tonic seizures J:131735
Kcna2tm1Tem/Kcna2tm1Tem
(involves: 129S7/SvEvBrd) 		seizures J:130097
Kcna4tm1Lndn/Kcna4tm1Lndn
(involves: 129S4/SvJae * C57BL/6) 		seizures J:48415
Kcnab2tm1Kmc/Kcnab2tm1Kmc
(involves: 129S7/SvEvBrd * C57BL/6) 		sporadic seizures J:75891
Kcnc1tm1Joho/Kcnc1tm1Joho
Kcnc3tm1Echa/Kcnc3tm1Echa
(involves: 129/Sv * C57BL/6) 		myoclonus J:71179
Kcnc2tm1Rudy/Kcnc2tm1Rudy
(B6.129S1-Kcnc2tm1Rudy) 		increased susceptibility to pharmacologically induced seizures J:66730
myoclonus J:66730
seizures J:66730
sporadic seizures J:66730
tonic-clonic seizures J:66730
Kcnh3tm1.2Tije/Kcnh3+
(involves: C57BL/6) 		abnormal spike wave discharge J:165296
Kcnh3tm1.2Tije/Kcnh3tm1.2Tije
(involves: C57BL/6) 		abnormal spike wave discharge J:165296
increased susceptibility to pharmacologically induced seizures J:165296
nonconvulsive seizures J:165296
Kcnip1tm1Zhzh/Kcnip1tm1Zhzh
(involves: C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:227383
Kcnj6tm1Stf/Kcnj6tm1Stf
(involves: 129S1/Sv * 129X1/SvJ) 		environmentally induced seizures J:38206
increased susceptibility to pharmacologically induced seizures J:38206
tonic-clonic seizures J:38206
Kcnj6tm1Stf/Kcnj6tm1Stf
Kcnj9tm1Kwn/Kcnj9tm1Kwn
(involves: 129S1/Sv * 129X1/SvJ) 		seizures J:77047
Kcnj6wv/Kcnj6wv
(C57BL/6J-Kcnj6wv) 		tonic-clonic seizures J:30520
Kcnj10tm1Kdmc/Kcnj10tm1Kdmc
Tg(GFAP-cre)1Kdmc/?
(involves: 129S6/SvEvTac * C3H * C57BL/6 * C57BL/6J * SJL) 		tonic-clonic seizures J:126082
Kcnj11tm1Sse/Kcnj11tm1Sse
(involves: 129P2/OlaHsd) 		convulsive seizures J:69832
myoclonus J:69832
tonic-clonic seizures J:69832
Kcnk2tm1Lzd/Kcnk2tm1Lzd
(involves: 129 * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:91531
Kcnmb4tm1Rwa/Kcnmb4tm1Rwa
(involves: 129X1/SvJ * C57BL/6) 		nonconvulsive seizures J:103931
Kcnq2Nmf134/Kcnq2+
(C57BL/6J-Kcnq2Nmf134/J) 		abnormal seizure response to electrical stimulation J:82238
Kcnq2Nmf134/Kcnq2+
(C57BL/6J-Kcnq2Nmf134) 		abnormal seizure response to electrical stimulation J:136510
increased susceptibility to pharmacologically induced seizures J:136510
Kcnq2Nmf134/Kcnq2+
Scn1atm1.1Aesc/Scn1a+
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6J) 		convulsive seizures J:170734
tonic-clonic seizures J:170734
Kcnq2Nmf134/Kcnq2+
Tg(Eno2-Scn2a1*)Q54Mm/0
(involves: C57BL/6J * SJL/J) 		seizures J:136510
tonic-clonic seizures J:136510
Kcnq2Nmf134/Kcnq2Nmf134
(C57BL/6J-Kcnq2Nmf134/J) 		abnormal seizure response to electrical stimulation J:82238
Kcnq2tm1.1Naas/Kcnq2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal seizure response to electrical stimulation J:154582
Kcnq2tm1.1Naas/Kcnq2tm1.1Naas
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		seizures J:154582
Kcnq2tm1.1Naas/Kcnq2tm1.1Naas
(B6.129-Kcnq2tm1.1Naas) 		tonic-clonic seizures J:154582
Kcnq2tm1.1Naas/Kcnq2tm1.1Naas
(FVB.129-Kcnq2tm1.1Naas) 		seizures J:154582
Kcnq2tm1Dgen/Kcnq2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Kcnq2tm1Hsa/Kcnq2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:62797
Kcnq2tm2.1Snhr/Kcnq2+
(B6.Cg-Kcnq2tm2.1Snhr) 		clonic seizures J:213443
Kcnq2tm2.1Snhr/Kcnq2tm2.1Snhr
(B6.Cg-Kcnq2tm2.1Snhr) 		clonic seizures J:213443
Kcnq2tm3.1Snhr/Kcnq2+
(B6.Cg-Kcnq2tm3.1Snhr) 		clonic seizures J:213443
Kcnq3tm1.1Naas/Kcnq3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal seizure response to electrical stimulation J:154582
Kcnq3tm1.1Naas/Kcnq3+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		abnormal seizure response to electrical stimulation J:154582
Kcnq3tm1.1Naas/Kcnq3tm1.1Naas
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		seizures J:154582
Kcnq3tm1.1Naas/Kcnq3tm1.1Naas
(B6.129-Kcnq3tm1.1Naas) 		seizures J:154582
Kcnq3tm1.1Naas/Kcnq3tm1.1Naas
(FVB.129-Kcnq3tm1.1Naas) 		seizures J:154582
Kdm1atm1Ebg/Kdm1atm1Ebg
(B6.129-Kdm1atm1Ebg) 		absence seizures J:235553
decreased susceptibility to pharmacologically induced seizures J:235553
tonic-clonic seizures J:235553
Kif5atm1.2Noh/Kif5atm1.2Noh
Tg(Syn1-cre)671Jxm/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA) 		seizures J:197666
Kif5atm1Gsn/Kif5atm2Gsn
Tg(Syn1-cre)671Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		sporadic seizures J:82911
Klk8tm1Lth/Klk8tm1Lth
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:71533
Klk14tm1.1(KOMP)Vlcg/Klk14+
(C57BL/6N-Klk14tm1.1(KOMP)Vlcg/J) 		convulsive seizures J:211773
L2hgdhGt(DC0625)Wtsi/L2hgdhGt(DC0625)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:228407
Letm1Gt(CC0204)Wtsi/Letm1+
(129S.129P2-Letm1Gt(CC0204)Wtsi) 		increased susceptibility to pharmacologically induced seizures J:222017
Letm1Gt(DD0926)Wtsi/Letm1+
(129S.129P2-Letm1Gt(DD0926)Wtsi) 		increased susceptibility to pharmacologically induced seizures J:222017
Lgi1tm1.1Ics/Lgi1+
(involves: 129S2/SvPas * BALB/c * C57BL/6) 		audiogenic seizures J:182795
Lgi1tm1.1Ics/Lgi1tm1.1Ics
(involves: 129S2/SvPas * BALB/c * C57BL/6) 		abnormal spike wave discharge J:182795
environmentally induced seizures J:182795
seizures J:182795
tonic-clonic seizures J:182795
Lgi1tm1.1Jkc/Lgi1tm1.1Jkc
Tyrc-Brd/Tyrc-Brd
(B6.Cg-Tyrc-Brd Lgi1tm1.1Jkc) 		clonic seizures J:158715
seizures J:158715
Lgi1tm1Mafu/Lgi1+
(involves: 129S6/SvEvTac * C57BL/6) 		clonic seizures J:157578
increased susceptibility to pharmacologically induced seizures J:157578
tonic seizures J:157578
Lgi1tm1Mafu/Lgi1tm1Mafu
(involves: 129S6/SvEvTac * C57BL/6) 		seizures J:157578
tonic-clonic seizures J:157578
Lgi1tm2.1Jkc/Lgi1tm2.1Jkc
Tg(CMV-cre)1Cgn/0
(involves: 129/Sv * BALB/cJ * C57BL/6) 		seizures J:269784
Lgi1tm2.1Jkc/Lgi1tm2.1Jkc
Tg(Nes-cre)1Kln/0
(involves: 129/Sv * C57BL/6 * SJL) 		seizures J:269784
Lhx6tm1Vpa/Lhx6tm2Vpa
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal spike wave discharge J:198547
environmentally induced seizures J:198547
increased susceptibility to pharmacologically induced seizures J:198547
tonic-clonic seizures J:198547
Loxl1tm1.1(KOMP)Vlcg/Loxl1tm1.1(KOMP)Vlcg
(C57BL/6N-Loxl1tm1.1(KOMP)Vlcg/J) 		convulsive seizures J:211773
m154Asp/m154Asp+
Tg(mI56i-lacZ)1Mekk/0
(involves: C57BL/6J * FVB/N) 		sporadic seizures J:136795
Macrod2tm1.1(KOMP)Vlcg/Macrod2tm1.1(KOMP)Vlcg
(C57BL/6N-Macrod2tm1.1(KOMP)Vlcg/J) 		convulsive seizures J:211773
Mafgtm1Jeng/Mafgtm1Jeng
Mafktm1Jeng/Mafk+
(involves: 129S1/Sv * 129X1/SvJ) 		myoclonus J:81813
Magtm1.1(KOMP)Vlcg/Magtm1.1(KOMP)Vlcg
(C57BL/6N-Magtm1.1(KOMP)Vlcg/J) 		convulsive seizures J:211773
Mapk10tm1Flv/Mapk10tm1Flv
(involves: 129S1/Sv) 		decreased susceptibility to pharmacologically induced seizures J:43658
Mapttm1Hnd/Mapt+
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:121330
Mapttm1Hnd/Mapt+
Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		decreased susceptibility to pharmacologically induced seizures J:121330
Mapttm1Hnd/Mapttm1Hnd
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:121330
Mapttm1Hnd/Mapttm1Hnd
Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		decreased susceptibility to pharmacologically induced seizures J:121330
Mbnl2tm1.1Sws/Mbnl2+
(involves: 129S1/SvImJ * BALB/cJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:218010
Mbnl2tm1.1Sws/Mbnl2tm1.1Sws
(involves: 129S1/SvImJ * BALB/cJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:218010
tonic-clonic seizures J:218010
Mbpjve/Mbpjve
(involves: C57BL/6J) 		absence seizures J:221049
environmentally induced seizures J:221049
tonic seizures J:221049
Mbpshi-mld+/Mbpshi-mld+
(involves: C3H/HeJ * C57BL/6J * MDB/Dt) 		convulsive seizures J:1873
Mbpshi-mld/Mbpshi-mld
(involves: MDB/Dt) 		sporadic seizures J:5917
Mbpshi/Mbpshi
(involves: C3H * ICR * SWV) 		audiogenic seizures J:6578
environmentally induced seizures J:6578
tonic seizures J:6578
Mbpshi/Mbpshi
Tg(Thy1-YFP)HJrs/0
(involves: C3HeB/Fe * C57BL/6 * CBA * SWV) 		increased susceptibility to pharmacologically induced seizures J:158545
Mc2rtm1Dgen/Mc2rtm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:82809
Mcoln3Va/Mcoln3+
(involves: C57BL * C57BR) 		tonic seizures J:13133
Mcoln3Va/Mcoln3Va
(involves: C57BL * C57BR) 		tonic seizures J:13133
Mecp2tm1.1Bird/Y
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N) 		seizures J:166851
Mecp2tm1.1Dhy/Y
(C57BL/6N-Mecp2tm1.1Dhy) 		seizures J:209069
Mecp2tm1.1Irsf/Mecp2+
(involves: 129S2/SvPas * C57BL/6) 		tonic-clonic seizures J:220859
Mecp2tm1.1Joez/Y
(B6.129-Mecp2tm1.1Joez) 		seizures J:181311
Mecp2tm1.1Jtc/Mecp2+
(involves: 129S6/SvEvTac * C57BL/6) 		tonic-clonic seizures J:209637
Mecp2tm1Bird/Y
Ssttm2.1(cre)Zjh/Sst+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		seizures J:228740
tonic-clonic seizures J:228740
Mecp2tm1Hzo/Y
(involves: 129S7/SvEvBrd * C57BL/6J) 		seizures J:78009
Mecp2tm1Pplt/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		sporadic seizures J:137513
Mecp2tm3Meg/Y
(B6.129-Mecp2tm3Meg) 		increased susceptibility to pharmacologically induced seizures J:204723
Mir128-2tm1.1Ans/Mir128-2tm1.1Ans
Tg(Camk2a-cre)2Gsc/0
(involves: BALB/cJ * C57BL/6J * FVB/N) 		seizures J:205260
Mir128-2tm1.1Ans/Mir128-2tm1.1Ans
Tg(Drd1-cre)EY262Gsat/0
(involves: BALB/cJ * C57BL/6J * FVB/N) 		seizures J:205260
Mir128-2tm1.2Ans/Mir128-2tm1.2Ans
(involves: BALB/cJ * C57BL/6J) 		seizures J:205260
Mir145atm1Eno/Mir145atm1Eno
(involves: 129S/SvEv * C57BL/6) 		seizures J:152458
Mirc32tm1.2Eno/Mirc32tm1.2Eno
(involves: 129S/SvEv * C57BL/6) 		seizures J:152458
Msx2tm1Rilm/Msx2tm1Rilm
(either: (involves: 129S4/SvJae) or (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6J)) 		tonic seizures J:61509
Mt1tm1Bri/Mt1tm1Bri
Mt2tm1Bri/Mt2tm1Bri
(129S7/SvEvBrd-Mt1tm1Bri Mt2tm1Bri/J) 		clonic seizures J:89429
increased susceptibility to pharmacologically induced seizures J:89429
tonic-clonic seizures J:89429
Mt3tm1Rpa/Mt3tm1Rpa
(involves: 129S7/SvEvBrd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:38222
Myh1tm1b(KOMP)Wtsi/Myh1tm1b(KOMP)Wtsi
(C57BL/6N-Myh1tm1b(KOMP)Wtsi/J) 		convulsive seizures J:211773
Myo3btm1b(EUCOMM)Hmgu/Myo3btm1b(EUCOMM)Hmgu
(C57BL/6N-Myo3btm1b(EUCOMM)Hmgu/J) 		convulsive seizures J:211773
Myo5ad-15H/Myo5ad-15H
(Not Specified) 		seizures J:13409
Myo5ad-l32J/Myo5ad-l32J
(B6.Cg-Myo5ad-l32J/GrsrJ) 		clonic seizures J:169210
Myo5ad-l/Myo5ad-l
(involves: C57BL) 		clonic seizures J:12978
Myo5ad-n2Btlr/Myo5ad-n2Btlr
(C57BL/6J-Myo5ad-n2Btlr) 		myoclonus J:133120
Myo5ad-n/Myo5ad-n
(B10.D2-H2d/nSnJ) 		clonic seizures J:171603
Myo5ad-nBtlr/Myo5ad-nBtlr
(C57BL/6J-Myo5ad-nBtlr) 		myoclonus J:133119
Myrftm1Barr/Myrftm1Barr
Cnptm1(cre)Kan/Cnp+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6) 		seizures J:150563
Myrftm1Barr/Myrftm1Barr
Olig2tm2(TVA,cre)Rth/Olig2+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6) 		seizures J:150563
Napbtm1Rhee/Napbtm1Rhee
(Not Specified) 		seizures J:167753
Ncdntm2Afu/Ncdntm2Afu
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		seizures J:99914
Ndufs4tm1.1Rpa/Ndufs4tm1.1Rpa
(involves: 129S4/SvJaeSor) 		environmentally induced seizures J:161393
seizures J:161393
Ndufs4tm1Rpa/Ndufs4tm1Rpa
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJaeSor * C57BL/6 * SJL) 		environmentally induced seizures J:161393
seizures J:161393
tonic-clonic seizures J:161393
nerv/nerv
(BALB/c-nerv) 		seizures J:227974
Neto1tm1Mci/Neto1tm1Mci
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:145953
Neu1tm1Adz/Neu1tm1Adz
(either: (involves: 129S1/Sv * C57BL/6) or (involves: 129S1/Sv * NMRI)) 		myoclonus J:76937
Neurod1tm1Mjts/Neurod1tm1Mjts
(involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6J) 		seizures J:59932
sporadic seizures J:59932
tonic-clonic seizures J:59932
Neurod2tm1Tap/Neurod2+
(involves: 129/Sv * C57BL/6) 		sporadic seizures J:69606
tonic-clonic seizures J:69606
Neurod2tm1Tap/Neurod2tm1Tap
(involves: 129/Sv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:69606
Nf1tm1Par/Nf1+
Ptentm1Hwu/Pten+
Trp53tm1Elee/Trp53+
Tg(GFAP-cre)25Mes/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * FVB/N) 		seizures J:134611
Nf1tm1Par/Nf1+
Ptentm1Hwu/Pten+
Trp53tm1Tyj/Trp53+
Tg(GFAP-cre)25Mes/0
(involves: 129S1/Sv * 129S2/SvPas * 129S4/SvJae * 129X1/SvJ * FVB/N) 		seizures J:134611
Nf1tm1Par/Nf1+
Trp53tm1Elee/Trp53+
Tg(GFAP-cre)25Mes/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * FVB/N) 		seizures J:134611
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac) 		increased susceptibility to pharmacologically induced seizures J:218959
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		abnormal seizure response to electrical stimulation J:210491
abnormal seizure response to pharmacological agent J:210491
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
Gys1tm1a(EUCOMM)Wtsi/Gys1+
Tg(Nes-cre)1Kag/?
(involves: C57BL/6NTac) 		abnormal seizure response to electrical stimulation J:210491
abnormal seizure response to pharmacological agent J:210491
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
Gys1tm1a(EUCOMM)Wtsi/Gys1tm1a(EUCOMM)Wtsi
Tg(Nes-cre)1Kag/?
(involves: C57BL/6NTac) 		abnormal seizure response to electrical stimulation J:210491
abnormal seizure response to pharmacological agent J:210491
Nhlrc1tm1.2Geno/Nhlrc1tm1.2Geno
(involves: 129S2/SvPas * C57BL/6J) 		abnormal spike wave discharge J:181559
myoclonus J:181559
Nid1tm1Dong/Nid1tm1Dong
(involves: 129P2/OlaHsd) 		sporadic seizures J:80843
Nmf31/Nmf31
(BALB/cByJ-Nmf31/J) 		myoclonus J:87349
Nmf31/Nmf31+
(BALB/cByJ-Nmf31/J) 		minimal clonic seizures J:78134
nmf88/nmf88
(C57BL/6J-nmf88/J) 		abnormal seizure response to electrical stimulation J:82238
nmf391/nmf391
(C57BL/6J-nmf391/J) 		myoclonus J:87349
Nos1tm1Plh/Nos1tm1Plh
(B6.129S4-Nos1tm1Plh) 		abnormal seizure response to inducing agent J:107964
Nos2tm1Lau/Nos2tm1Lau
(B6.129P2-Nos2tm1Lau) 		increased susceptibility to pharmacologically induced seizures J:107300
Nos3tm1Plh/Nos3tm1Plh
(B6.129S4-Nos3tm1Plh) 		abnormal seizure response to inducing agent J:107964
Npas4tm1Meg/Npas4tm1Meg
(involves: C57BL/6) 		seizures J:143367
Npas4tm1Ooe/Npas4tm1Ooe
(involves: 129/Sv * C57BL/6) 		myoclonus J:145569
Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:124729
Npytm1Rpa/Npytm1Rpa
(involves: 129S7/SvEvBrd) 		increased susceptibility to pharmacologically induced seizures J:33261
sporadic seizures J:33261
Npytm2Rpa/Npytm2Rpa
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:104699
Nr4a3tm1Omc/Nr4a3tm1Omc
(involves: 129S/SvEv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:93320
tonic-clonic seizures J:93320
Nrp2tm1.2Mom/Nrp2+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/NJ) 		environmentally induced seizures J:166116
increased susceptibility to pharmacologically induced seizures J:166116
myoclonus J:166116
seizures J:166116
Nrp2tm1.2Mom/Nrp2tm1.2Mom
(involves: 129P2/OlaHsd * C57BL/6 * FVB/NJ) 		environmentally induced seizures J:166116
increased susceptibility to pharmacologically induced seizures J:166116
myoclonus J:166116
seizures J:166116
Ntrk2tm1Jom/Ntrk2+
Tg(Syn1-cre)671Jxm/0
(involves: 129/Sv * C57BL/6 * ICR) 		reduced kindling response J:91467
Ntrk2tm1Jom/Ntrk2tm1Jom
Tg(Syn1-cre)671Jxm/0
(involves: 129/Sv * C57BL/6 * ICR) 		reduced kindling response J:91467
nur8/nur8
(Not Specified) 		seizures J:85113
nur33/nur33
(Not Specified) 		myoclonus J:89098
Nur37/Nur37+
(Not Specified) 		seizures J:89098
Oprd1tm1Dgen/Oprd1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Otcspf/Y
(involves: C3H/HeJ * C57BL/6J) 		tonic-clonic seizures J:31237
Otud7aem1Cpsc/Otud7aem1Cpsc
(C57BL/6J-Otud7aem1Cpsc) 		abnormal spike wave discharge J:259730
Otx1tm1Asim/Otx1tm1Asim
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		convulsive seizures J:35640
nonconvulsive seizures J:35640
Otx1tm1Asim/Otx1tm1Asim
(involves: 129P2/OlaHsd) 		seizures J:52989
P2rx6tm1Dgen/P2rx6tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased susceptibility to pharmacologically induced seizures J:82809
Pacsin1tm1.1Bqu/Pacsin1tm1.1Bqu
(Not Specified) 		tonic-clonic seizures J:180017
Pahm1Btlr/Pahm1Btlr
(C57BL/6J-Pahm1Btlr) 		audiogenic seizures J:152890
environmentally induced seizures J:152890
Panx1tm1.1Fama/Panx1tm1.1Fama
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:177671
Panx1tm1a(KOMP)Wtsi/Panx1tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N) 		decreased susceptibility to pharmacologically induced seizures J:177671
Pcmt1tm1Scl/Pcmt1tm1Scl
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:40967
tonic-clonic seizures J:40967
Pcmt1tm1Shs/Pcmt1tm1Shs
(involves: 129P2/OlaHsd * C57BL/6) 		clonic seizures J:46228
convulsive seizures J:46228
myoclonus J:46228
tonic-clonic seizures J:46228
Pcntm239Asp/Pcnt+
Tg(mI56i-lacZ)1Mekk/0
(involves: C57BL/6J * FVB/N) 		sporadic seizures J:136795
Pcntm275Asp/Pcnt+
Tg(mI56i-lacZ)1Mekk/0
(involves: C57BL/6J * FVB/N) 		sporadic seizures J:136795
Pde8atm1Dgen/Pde8atm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:82809
Pdgfratm6Sor/Pdgfratm6Sor
(either: 129S4/SvJaeSor-Pdgfratm6Sor or (involves: 129S4/SvJaeSor * C57BL/6J)) 		seizures J:73817
Pdyntm1(cre)Czer/Pdyn+
(B6.Cg-Pdyntm1(cre)Czer) 		increased susceptibility to pharmacologically induced seizures J:122651
Pdyntm1(cre)Czer/Pdyntm1(cre)Czer
(B6.Cg-Pdyntm1(cre)Czer) 		increased susceptibility to pharmacologically induced seizures J:122651
Phf6em1Azbi/Y
(B6.Cg-Phf6em1Azbi) 		increased susceptibility to pharmacologically induced seizures J:271089
Pis1A/J/Pis1A/J
(C57BL/6J-Chr 10A/J/NaJ) 		increased susceptibility to pharmacologically induced seizures J:118211
Pis2A/J/Pis2A/J
(C57BL/6J-Chr 18A/J/NaJ) 		increased susceptibility to pharmacologically induced seizures J:118211
PitpnaGt(OST1152)Lex/PitpnaGt(OST1152)Lex
(involves: 129S5/SvEvBrd) 		seizures J:85204
Pitpnatm1Vab/Pitpnatm1Vab
(involves: 129S7/SvEvBrd) 		seizures J:85204
Plaurtm1Mlg/Plaurtm1Mlg
(B6.Cg-Plaurtm1Mlg) 		increased susceptibility to pharmacologically induced seizures J:81735
myoclonus J:81735
Plcb1tm1Hssh/Plcb1tm1Hssh
(Not Specified) 		convulsive seizures J:43077
increased susceptibility to pharmacologically induced seizures J:43077
Plcl1tm1Mh/Plcl1tm1Mh
(involves: 129/Sv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:92956
seizures J:92956
Plp1jp-4J/Y
(involves: C3H/HeJ * C57BL/6J) 		seizures J:41569
Plp1jp-msd/Y
(involves: C57BL/10Sn * BALB/cJ) 		seizures J:5170
Plp1jp-rsh/Y
(involves: C57BL/6NCrl) 		seizures J:88023
Plp1jp/Y
(Not Specified) 		environmentally induced seizures J:288
tonic-clonic seizures J:13141
Plppr4tm1Roni/Plppr4tm1Roni
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:157318
tonic-clonic seizures J:157318
Pmp22tm1Ueli/Pmp22tm1Ueli
(involves: 129S/SvEv) 		convulsive seizures J:29517
Pmp22Tr/?
(Not Specified) 		seizures J:7222
Pmp22Tr/Pmp22+
(Not Specified) 		convulsive seizures J:13038
Ppargc1atm1Brsp/Ppargc1atm1Brsp
(involves: 129/Sv * C57BL/6 * FVB/N) 		myoclonus J:93896
Ppp1r9btm1Jfe/Ppp1r9btm1Jfe
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:77284
Ppt1tm1Aj/Ppt1tm1Aj
(involves: 129S4/SvJae * C57BL/6) 		myoclonus J:95522
seizures J:95522
Ppt1tm1Hof/Ppt1tm1Hof
(involves: 129S6/SvEvTac * C57BL/6J) 		myoclonus J:72931
Prickle1m1Ingm/Prickle1+
(involves: C57BL/6) 		abnormal seizure response to electrical stimulation J:169136
Prickle1m2Ingm/Prickle1+
(C57BL/6-Prickle1m2Ingm) 		abnormal seizure response to electrical stimulation J:169136
Prickle1tm1Nue/Prickle1+
(B6.Cg-Prickle1tm1Nue) 		abnormal seizure response to electrical stimulation J:169136
Prickle2tm1Nue/Prickle2+
(B6.Cg-Prickle2tm1Nue) 		abnormal seizure response to electrical stimulation J:169136
Prickle2tm1Nue/Prickle2tm1Nue
(B6.Cg-Prickle2tm1Nue) 		abnormal seizure response to electrical stimulation J:169136
increased susceptibility to pharmacologically induced seizures J:169136
Prkab1Gt(RRR454)Byg/Prkab1Gt(RRR454)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:146618
Prnptm1Cwe/Prnptm1Cwe
Tg(Prnp*)#Rgab/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N) 		myoclonus J:183170
Prrt2tm1a(KOMP)Wtsi/Prrt2tm1a(KOMP)Wtsi
(C57BL/6N-Atm1Brd Prrt2tm1a(KOMP)Wtsi/Wtsi) 		audiogenic seizures J:237823
increased susceptibility to pharmacologically induced seizures J:237823
Psaptm1Suz/Psaptm1Suz
(involves: 129P2/OlaHsd) 		seizures J:113052
tonic seizures J:33477
Psaptm2Suz/Psaptm2Suz
(involves: 129S/SvEv * C57BL/6J) 		seizures J:78223
psrt1R/psrt1R
(involves: BJR) 		seizures J:73982
psrt2R/psrt2R
(involves: BJR) 		seizures J:73982
Ptentm1Rdp/Pten+
Trp53tm1Brn/Trp53tm1Brn
Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * FVB/N) 		seizures J:140704
Ptentm2Mak/Ptentm2Mak
Tg(Eno2-cre)39Jme/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		sporadic seizures J:109635
Ptentm2Mak/Ptentm2Mak
Tg(Gfap-cre)1Sbk/0
(involves: 129P2/OlaHsd) 		abnormal spike wave discharge J:149829
seizures J:75500
tonic-clonic seizures J:149829
Ptentm2Mak/Ptentm2Mak
Tg(Nes-cre/ERT2,-ALPP)1Sbk/0
(involves: 129P2/OlaHsd) 		seizures J:237990
Ptgs2tm1Unc/Ptgs2tm1Unc
(B6;129P2-Ptgs2tm1Unc/Tac) 		increased susceptibility to pharmacologically induced seizures J:141610
tonic-clonic seizures J:141610
Ptprotm1Dgen/Ptprotm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Puratm1Kkh/Pura+
(involves: 129) 		seizures J:85759
Puratm1Kkh/Puratm1Kkh
(involves: 129) 		seizures J:85759
Qke5/Qke5
(B6.101Rl-Qke5) 		seizures J:102038
Qke5/Qkqk-k2
(involves: 101/Rl * C57BL/6J * CBA/Ca) 		seizures J:102038
Qke5/Qkqk-kt1
(involves: 101/Rl * C57BL/6J) 		seizures J:102038
Qkqk-shk/Qkqk-shk
(involves: 129 * C57BL/6) 		tonic seizures J:220956
Qkqk-v/Qkqk-v
(B6C3Fe a/a-Qkqk-v/J) 		seizures J:102038
Qkqk-v/Qkqk-v
(involves: C3H/Di * DBA/2J) 		tonic seizures J:13141
Rai1tm1Jrl/Rai1+
(involves: 129S/SvEvBrd * C57BL/6) 		seizures J:125089
Rai1tm1Jrl/Rai1tm1Jrl
(involves: 129S/SvEvBrd * C57BL/6) 		seizures J:125089
tonic-clonic seizures J:125089
Rbfox1tm1.1Dblk/Rbfox1+
Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * SJL) 		increased susceptibility to pharmacologically induced seizures J:176189
Rbfox1tm1.1Dblk/Rbfox1tm1.1Dblk
Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * SJL) 		increased susceptibility to pharmacologically induced seizures J:176189
seizures J:176189
tonic-clonic seizures J:176189
Rbfox3tm1a(EUCOMM)Hmgu/Rbfox3tm1a(EUCOMM)Hmgu
(B6Dnk;B6N-Rbfox3tm1a(EUCOMM)Hmgu/H) 		increased susceptibility to pharmacologically induced seizures J:234043
Rgsc73/Rgsc73+
(involves: C57BL/6JJcl * DBA/2JJcl) 		convulsive seizures J:133634
Rnd3Gt(OST364657)Lex/Rnd3Gt(OST364657)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		convulsive seizures J:172361
Rnf10tm1b(KOMP)Wtsi/Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/J) 		convulsive seizures J:211773
Ryr2tm1Slh/Ryr2+
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:235432
Ryr2tm2Amks/Ryr2+
(B6.129-Ryr2tm2Amks) 		increased susceptibility to pharmacologically induced seizures J:137696
tonic-clonic seizures J:137696
Ryr2tm2Amks/Ryr2tm2Amks
(B6.129-Ryr2tm2Amks) 		increased susceptibility to pharmacologically induced seizures J:137696
tonic-clonic seizures J:137696
S1pr2tm1Ajml/S1pr2tm1Ajml
(involves: 129S5/SvEvBrd * C57BL/6) 		seizures J:73957
tonic-clonic seizures J:73957
S1pr2tm1Ajml/S1pr2tm1Ajml
(either: (involves: 129S5/SvEvBrd) or (involves: 129S5/SvEvBrd * C57BL/6)) 		seizures J:112371
S1pr2tm1Ytak/S1pr2tm1Ytak
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:168060
Scg5tm1Led/Scg5tm1Led
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * FVB) or (involves: 129S6/SvEvTac * C57BL/6)) 		convulsive seizures J:77510
Scn1atm1.1Aesc/Scn1a+
(involves: 129X1/SvJ * C57BL/6J * SJL) 		abnormal spike wave discharge J:161191
environmentally induced seizures J:161191
increased susceptibility to pharmacologically induced seizures J:161191
seizures J:161191
tonic seizures J:161191
tonic-clonic seizures J:161191
Scn1atm1.1Aesc/Scn1a+
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:170734
Scn1atm1.1Aesc/Scn1a+
Tg(Eno2-Scn2a1*)Q54Mm/0
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6J * SJL/J) 		convulsive seizures J:170734
tonic-clonic seizures J:170734
Scn1atm1.1Aesc/Scn1atm1.1Aesc
(involves: 129X1/SvJ * C57BL/6J * SJL) 		clonic seizures J:161191
environmentally induced seizures J:161191
maximal tonic hindlimb extension seizures J:161191
seizures J:161191
tonic seizures J:161191
Scn1atm1.1Kzy/Scn1a+
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:121969
Scn1atm1.1Kzy/Scn1a+
(involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J) 		convulsive seizures J:209093
increased susceptibility to pharmacologically induced seizures J:209093
Scn1atm1.1Kzy/Scn1a+
(involves: 129P2/OlaHsd * C3HeB/FeJ) 		environmentally induced seizures J:260796
seizures J:260796
Scn1atm1.1Swl/Scn1a+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6JNarl) 		environmentally induced seizures J:221045
tonic-clonic seizures J:221045
Scn1atm1.1Swl/Scn1atm1.1Swl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6JNarl) 		tonic-clonic seizures J:221045
Scn1atm1Kea/Scn1a+
((C57BL/6J x 129S6/SvEvTac-Scn1atm1Kea)F1) 		seizures J:203040
Scn1atm1Kzy/Scn1a+
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:121969
Scn1atm1Kzy/Scn1atm1Kzy
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:121969
tonic seizures J:121969
tonic-clonic seizures J:121969
Scn1atm1Wac/Scn1a+
(B6.129-Scn1atm1Wac) 		seizures J:113149
Scn1atm1Wac/Scn1a+
(involves: 129S1/Sv * 129X1/SvJ * FVB/NJ) 		abnormal spike wave discharge J:129998
increased susceptibility to pharmacologically induced seizures J:129998
tonic-clonic seizures J:129998
Scn1atm1Wac/Scn1a+
Scn8amed-jo/Scn8a+
(involves: 129 * C57BL/6J * DBA/2WyDi * FVB/NJ) 		abnormal spike wave discharge J:129998
Scn1atm1Wac/Scn1atm1Wac
(B6.129-Scn1atm1Wac) 		clonic seizures J:113149
convulsive seizures J:113149
seizures J:113149
Scn1atm2.1Kzy/Scn1a+
Tg(Pvalb-cre)1Tama/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		convulsive seizures J:202863
Scn1atm2.1Kzy/Scn1a+
Tg(Slc32a1-cre)65Kzy/0
(involves: 129P2/OlaHsd * C57BL/6) 		convulsive seizures J:202863
Scn1atm2.1Kzy/Scn1atm2.1Kzy
Tg(Pvalb-cre)1Tama/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		convulsive seizures J:202863
Scn1atm2.1Kzy/Scn1atm2.1Kzy
Tg(Slc32a1-cre)65Kzy/0
(involves: 129P2/OlaHsd * C57BL/6) 		convulsive seizures J:202863
Scn1atm2.1Wac/Scn1a+
Tg(I12b-cre)1Jlr/0
(involves: C57BL/6J * CD-1) 		clonic seizures J:189897
environmentally induced seizures J:189897
seizures J:189897
tonic-clonic seizures J:189897
Scn1atm2.2Kzy/Scn1a+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		convulsive seizures J:202863
Scn1atm2.2Kzy/Scn1atm2.2Kzy
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		convulsive seizures J:202863
Scn1btm1.1Bion/Scn1b+
(Not Specified) 		environmentally induced seizures J:163771
Scn1btm1.1Bion/Scn1btm1.1Bion
(Not Specified) 		environmentally induced seizures J:163771
seizures J:163771
tonic-clonic seizures J:163771
Scn1btm1Isom/Scn1btm1Isom
(involves: 129X1/SvJ * C57BL/6) 		seizures J:90136
Scn1btm2.1Isom/Scn1btm2.1Isom
(involves: 129X1/SvJ * C57BL/6) 		seizures J:128713
Scn2btm1Isom/Scn2btm1Isom
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:82050
Scn5atm1Clhh/Scn5a+
(involves: 129 * 129S/SvEv * C57BL/6J) 		seizures J:127879
Scn8a7J/Scn8a7J
(involves: BALB/cByJ * C57BL/6J) 		myoclonus J:87349
Scn8a8J/Scn8a8J
(involves: C3HeB/FeJ * C57BL/6J) 		abnormal spike wave discharge J:147199
Scn8a8J/Scn8a+
(involves: C3HeB/FeJ * C57BL/6J) 		abnormal spike wave discharge J:147199
Scn8aem1Mm/Scn8a+
(involves: C57BL/6J * SJL) 		seizures J:207931
Scn8amed-jo/Scn8a+
(B6.D2-Scn8amed-jo/J) 		abnormal spike wave discharge J:147199
decreased susceptibility to pharmacologically induced seizures J:129998, J:170734
Scn8amed/Scn8a+
(C3Fe.Cg-Scn8amed/J) 		abnormal spike wave discharge J:147199
decreased susceptibility to pharmacologically induced seizures J:129998
Scn9atm1.1Naas/Scn9atm1.1Naas
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal seizure response to electrical stimulation J:154118
minimal clonic seizures J:154118
Scn9atm1.1Naas/Scn9atm1.1Naas
(B6.129-Scn9atm1.1Naas) 		abnormal kindling response J:154118
Senp2tm1Eyeh/Senp2tm1Eyeh
(Not Specified) 		audiogenic seizures J:217910
convulsive seizures J:217910
Serpine2tm1Dmn/Serpine2tm1Dmn
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:40953
Sez6tm1.1Sest/Sez6tm1.1Sest
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased susceptibility to pharmacologically induced seizures J:132725
Sgcetm1Ygl/Sgce+
(involves: 129S2/SvPas) 		myoclonus J:180682
Sgcetm1Ygl/Sgcetm1Ygl
(involves: 129S2/SvPas * 129S4/SvJaeSor * BALB/c * C57BL/6) 		myoclonus J:101332
Sh3gl1tm1Pdc/Sh3gl1tm1Pdc
Sh3gl2tm1Pdc/Sh3gl2+
Sh3gl3tm1.2Itl/Sh3gl3tm1.2Itl
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * FVB/N * SJL) 		seizures J:178947
Sh3gl1tm1Pdc/Sh3gl1tm1Pdc
Sh3gl2tm1Pdc/Sh3gl2tm1Pdc
(involves: 129) 		seizures J:178947
Shank3tm1.1Cgen/Shank3tm1.1Cgen
(B6.Cg-Shank3tm1.1Cgen) 		decreased susceptibility to pharmacologically induced seizures J:281328
Shank3tm2Gfng/Shank3tm2Gfng
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		environmentally induced seizures J:171113
Shhtm2Amc/Shhtm2Amc
Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		seizures J:102950
Sicd1C57BL/6J/Sicd1C57BL/6J
(FVB.B6-(D18Mit141-D18Mit25)) 		increased susceptibility to pharmacologically induced seizures J:122922
sims/sims
(B6.Cg-sims/GrsrJ) 		audiogenic seizures J:161505
sims/sims+
(B6.Cg-sims/GrsrJ) 		environmentally induced seizures J:161505
Slc1a2tm1.1Ncd/Slc1a2tm1.1Ncd
Tg(Nes-cre)1Kln/0
(B6.Cg-Slc1a2tm1.1Ncd Tg(Nes-cre)1Kln) 		seizures J:207177
Slc1a2tm1.1Pros/Slc1a2tm1.1Pros
Tg(GFAP-cre/ERT2)13Kdmc/0
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6) 		seizures J:221590
Slc1a2tm1Kta/Slc1a2tm1Kta
(involves: 129P2/OlaHsd * C57BL/6) 		convulsive seizures J:40984
increased susceptibility to pharmacologically induced seizures J:40984
Slc1a3tm1Kta/Slc1a3tm1Kta
(involves: 129P2/OlaHsd) 		abnormal kindling response J:58180
increased susceptibility to pharmacologically induced seizures J:58180
seizures J:58180
Slc2a1tm1Dcdv/Slc2a1+
(involves: 129S6/SvEvTac * C57BL/6J) 		sporadic seizures J:108250
Slc4a3tm1Cahb/Slc4a3tm1Cahb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:104157
Slc4a10tm1.1Cahb/Slc4a10tm1.1Cahb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:131058
Slc6a5trsl/Slc6a5trsl
(C57BL/6J-Slc6a5trsl/GrsrJ) 		tonic seizures J:235637
Slc6a11tm1Dgen/Slc6a11+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:101679
Slc7a8tm1Dgen/Slc7a8tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:101679
Slc7a10tm1Dgen/Slc7a10tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		myoclonus J:100127
seizures J:100127
tonic-clonic seizures J:100127
Slc9a1swe/Slc9a1swe
(SJL/J-Slc9a1swe/J) 		seizures J:43429
tonic-clonic seizures J:43429
Slc9a1swe/Slc9a1swe
(B6.SJL-Slc9a1swe) 		seizures J:43429
tonic-clonic seizures J:43429
Slc9a1swe/Slc9a1swe
(involves: C57BL/6J * SJL/J) 		absence seizures J:43429
seizures J:43429
tonic-clonic seizures J:43429
Slc9a1tm1Smb/Slc9a1tm1Smb
(involves: 129X1/SvJ * Black Swiss) 		convulsive seizures J:54705
Slc9a6tm1Dgen/Y
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Slc10a4tm1Tigm/Slc10a4tm1Tigm
(involves: 129S/SvEvBrd) 		abnormal spike wave discharge J:196996
increased susceptibility to pharmacologically induced seizures J:196996
seizures J:196996
Slc12a5tm1Dlp/Slc12a5+
(involves: C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:113307
Slc12a5tm1Dlp/Slc12a5tm1Dlp
(involves: 129 * C57BL/6J) 		tonic-clonic seizures J:113307
Slc12a5tm1Hsav/Slc12a5tm2Hsav
(involves: 129S1/Sv * 129S2/SvPasHsd * 129X1/SvJ * C57BL/6J * C57BL/6JOlaHsd) 		increased susceptibility to pharmacologically induced seizures J:101079
Slc12a6tm1Tjj/Slc12a6tm1Tjj
(involves: 129/Sv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:86183
Slc13a1tm1Mark/Slc13a1+
(involves: 129T2/SvEms * C57BL/6J) 		clonic seizures J:86561
Slc13a1tm1Mark/Slc13a1tm1Mark
(involves: 129T2/SvEms * C57BL/6J) 		clonic seizures J:86561
Slc17a5tm1Lex/Slc17a5tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		environmentally induced seizures J:158444
tonic-clonic seizures J:158444
Slc17a8tm1Edw/Slc17a8tm1Edw
(involves: 129P2/OlaHsd * C57BL/6) 		nonconvulsive seizures J:132704
Slc18a3tm1Mca/Slc18a3tm1Mca
(involves: 129S4/SvJae * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:136620
Slc25a12Gt(OST123999)Lex/Slc25a12Gt(OST123999)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		convulsive seizures J:101164
Slc25a46atc/Slc25a46atc
(B6.Cg-Slc25a46atc) 		tonic-clonic seizures J:242350
Slc37a4tm1Jyc/Slc37a4tm1Jyc
(involves: 129S4/SvJae * C57BL/6) 		seizures J:86005
Slitrk3tm1Jaru/Slitrk3tm1Jaru
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:232385
seizures J:232385
Smarcb1tm2Sho/Smarcb1tm2Sho
Trp53tm1Brn/Trp53tm1Brn
Tg(GFAP-cre)#Gtm/0
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6 * CBA) 		seizures J:226786
Snap25tm1.1Bark/Snap25tm1.1Bark
(B6.Cg-Snap25tm1.1Bark) 		seizures J:142096
Snap25tm1Bark/Snap25tm1Bark
(B6.Cg-Snap25tm1Bark) 		seizures J:142096
Snap25tm1Mtaka/Snap25tm1Mtaka
(B6N.129P2-Snap25tm1Mtaka) 		convulsive seizures J:177870
Snap25tm2Mcw/Snap25tm2Mcw
(involves: C57BL/6J) 		myoclonus J:94005
Snap91tm1.1Tmar/Snap91tm1.1Tmar
(involves: 129S6/SvEvTac * C57BL/6NTac) 		tonic-clonic seizures J:228428
Sod2tm1Cje/Sod2tm1Cje
(involves: C57BL/6J * DBA/2J) 		seizures J:73998, J:98007
Sox1tm1Vep/Sox1tm1Vep
(either: (involves: 129/Sv * 129S/SvEv) or (involves: 129S/SvEv * MF1)) 		seizures J:46636
Sox1tm1Vep/Sox1tm2Vep
Sox2tm1Vep/Sox2+
(involves: 129S/SvEv) 		seizures J:99610
Sox1tm2Vep/Sox1tm2Vep
(Not Specified) 		seizures J:99610
Sox2tm2Skn/Sox2tm3Skn
(involves: 129S/SvEv * 129S1/Sv * C57BL/6J) 		nonconvulsive seizures J:92063
Sox10gt/Sox10gt
(involves: HYIII/LeJ) 		sporadic seizures J:7723
Sox10gt/Sox10gt
(involves: C57BL/6 * GT/Le) 		seizures J:216967
sps/sps
(involves: C57BL/10Bg) 		convulsive seizures J:32781, J:12239
Sptbn2Gt(XK442)Byg/Sptbn2Gt(XK442)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		clonic seizures J:158494
St3gal4tm1.1Bsi/St3gal4tm1.1Bsi
(B6J.B6N-St3gal4tm1.1Bsi) 		reduced kindling response J:217104
Stamtm1Sug/Stamtm1Sug
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:69504
Stx1btm1.1Sud/Stx1btm1.1Sud
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		seizures J:138035
Sult4a1em1Uab/Sult4a1em1Uab
(C57BL/6J-Sult4a1em1Uab) 		absence seizures J:280143
Sult4a1em2Uab/Sult4a1em2Uab
(C57BL/6J-Sult4a1em2Uab) 		absence seizures J:280143
Sumf1Gt(RST760)Byg/Sumf1Gt(RST760)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:120146
Sv2atm1Baj/Sv2a+
(Not Specified) 		seizures J:59073
Sv2atm1Baj/Sv2atm1Baj
(Not Specified) 		seizures J:59073
Sv2atm1Baj/Sv2atm1Baj
(involves: 129X1/SvJ * C57BL/6) 		seizures J:70828
Sv2atm1Baj/Sv2atm1Baj
Sv2btm1Baj/Sv2btm1Baj
(involves: 129 * C57BL/6) 		seizures J:70828
Sv2atm1Sud/Sv2atm1Sud
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:59180
Sv2atm1Sud/Sv2atm1Sud
Sv2btm1Sud/Sv2btm1Sud
(involves: 129P2/OlaHsd * C57BL/6) 		seizures J:59180
Sv2btm1Baj/Sv2btm1Baj
(involves: 129 * C57BL/6) 		seizures J:70828
Syn1tm1Pggd/Syn1tm1Pggd
(involves: 129) 		abnormal seizure response to electrical stimulation J:29086
Syn1tm1Pggd/Syn1tm1Pggd
Syn2tm1Pggd/Syn2tm1Pggd
Syn3tm1Pggd/Syn3tm1Pggd
(involves: 129 * 129P2/OlaHsd * 129X1/SvJ * C57BL/6) 		environmentally induced seizures J:175256
tonic-clonic seizures J:175256
Syn1tm1Sud/Syn1tm1Sud
(involves: 129S7/SvEvBrd) 		convulsive seizures J:15701
Syn1tm1Sud/Syn1tm1Sud
Syn2tm1Sud/Syn2tm1Sud
(involves: 129S7/SvEvBrd) 		convulsive seizures J:26920
Syn2tm1Pggd/Syn2tm1Pggd
(Not Specified) 		seizures J:202031
Syn2tm1Sud/Syn2tm1Sud
(involves: 129S7/SvEvBrd) 		convulsive seizures J:26920
Syn3tm1.1(KOMP)Vlcg/Syn3tm1.1(KOMP)Vlcg
(C57BL/6N-Syn3tm1.1(KOMP)Vlcg/J) 		convulsive seizures J:211773
Syngap1tm1Rlh/Syngap1+
(involves: 129S1/Sv * 129X1/SvJ) 		audiogenic seizures J:193208
increased susceptibility to pharmacologically induced seizures J:193208
Syngr1tm1Sud/Syngr1tm1Sud
Syngr3tm1Sud/Syngr3tm1Sud
Synprtm1Sud/Synprtm1Sud
Syptm1Sud/Syptm1Sud
(Not Specified) 		seizures J:156812
Synj1tm1Pdc/Synj1tm1Pdc
(involves: 129S1/Sv * C57BL/6) 		convulsive seizures J:58087
Szs1C57BL/6J/Szs1DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:56630
seizures J:38888
Szs1DBA/2J/Szs1DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:56630
seizures J:38888
Szs1DBA/2J/Szs1DBA/2J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szs1DBA/2J/Szs1DBA/2J
(involves: B6.D2-Mtv7a/Ty * C57BL/6J) 		abnormal seizure response to electrical stimulation J:89732
Szs2C57BL/6J/Szs2C57BL/6J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:38888
Szs2C57BL/6J/Szs2DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:38888
Szs5DBA/2J/?
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:56630
Szs6C57BL/6J/?
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:56630
Szs7DBA/2J/?
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:70295
Szs8DBA/2J/Szs8C57BL/6J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:70295
Szs8DBA/2J/Szs8DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:70295
Szs9C57BL/6J/Szs9DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:70295
Szs9DBA/2J/Szs9DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:70295
Szs10C57BL/6J/Szs10C57BL/6J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szs10C57BL/6J/Szs10DBA/2J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szs11C57BL/6J/Szs11C57BL/6J
(D2.B6-(D5Mit345-D5Mit403)) 		abnormal seizure response to electrical stimulation J:129499
Szs11DBA/2J/Szs11C57BL/6J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szs11DBA/2J/Szs11DBA/2J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szs11DBA/2J/Szs11DBA/2J
(B6.D2-(D5Mit75-D5Mit403)) 		abnormal seizure response to electrical stimulation J:129499
Szs12DBA/2J/Szs12C57BL/6J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szs12DBA/2J/Szs12DBA/2J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szs13DBA/2J/Szs13C57BL/6J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szs13DBA/2J/Szs13DBA/2J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szt1/Szt1+
(involves: BALB/cByJ * BALB/cJ * C57BL/6J) 		abnormal seizure response to electrical stimulation J:82964
abnormal seizure response to pharmacological agent J:82964
Szt1/Szt1+
(C57BL/6J-Szt1) 		abnormal seizure response to electrical stimulation J:136510
Szt1/Szt1+
Tg(Eno2-Scn2a1*)Q54Mm/0
(involves: C57BL/6J * SJL/J) 		seizures J:136510
tonic-clonic seizures J:136510
Szt2Gt(XH662)Byg/Szt2+
(involves: 129P2/OlaHsd * C57BL/6J) 		minimal clonic seizures J:150942
Szt2Gt(XH662)Byg/Szt2Gt(XH662)Byg
(129S1.129P2(B6)-Szt2Gt(XH662)Byg/FrkJ) 		maximal tonic hindlimb extension seizures J:150942
minimal clonic seizures J:150942
Szt2Gt(XH662)Byg/Szt2m1Frk
(involves: 129P2/OlaHsd * C57BL/6J) 		minimal clonic seizures J:150942
Szt2m1Frk/Szt2m1Frk
(C57BL/6J-Szt2m1Frk) 		abnormal kindling response J:150942
minimal clonic seizures J:150942
Szt2m1Frk/Szt2m1Frk
(involves: BALB/cByJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:150942
minimal clonic seizures J:150942
tonic-clonic seizures J:150942
Szv1C57BL/6J/Szv1C57BL/6J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:38888
Szv2C57BL/6J/Szv2C57BL/6J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:38888
Szv2C57BL/6J/Szv2DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:38888
Szv3C57BL/6J/Szv3DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:70295
Szv3DBA/2J/Szv3DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:70295
Tal2tm1Thr/Tal2tm1Thr
(involves: 129 * C57BL/6) 		convulsive seizures J:65762
Tbc1d24em2Tbf/Tbc1d24em2Tbf
(C57BL/6J-Tbc1d24em2Tbf) 		tonic-clonic seizures J:273646
Tcf12tm2Zhu/Tcf12+
(Not Specified) 		seizures J:120411
Tectatm3.1Gpr/Tecta+
(involves: 129S/SvEv) 		audiogenic seizures J:203482
Tectatm4.1Gpr/Tecta+
(involves: 129S/SvEv) 		audiogenic seizures J:203482
Tectatm5.1Gpr/Tecta+
(involves: 129S/SvEv) 		audiogenic seizures J:203482
Teftm1Schb/Teftm1Schb
(involves: 129S2/SvPas) 		absence seizures J:90854
seizures J:90854
Tg(AGT)2-5Afu/0
(involves: C57BL/6) 		convulsive seizures J:130455
Tg(APPswe,PSEN1dE9)85Dbo/0
(B6.Cg-Tg(APPswe,PSEN1dE9)85Dbo/Mmjax) 		convulsive seizures J:227541
Tg(APPswe,PSEN1dE9)85Dbo/0
(D2.Cg-Tg(APPswe,PSEN1dE9)85Dbo) 		convulsive seizures J:227541
Tg(ATN1*)Q129Stsu/0
(involves: 129S/SvEv * C57BL/6J) 		absence seizures J:144379
Tg(C9orf72)500Lpwr/0
(FVB/NJ-Tg(C9orf72)500Lpwr) 		seizures J:239579
Tg(CAG-cre/Esr1*)5Amc/0
Ube3atm1Yelg/Ube3a+
(involves: 129P2/OlaHsd * 129S2/SvPasCrl * C57BL/6J) 		audiogenic seizures J:222400
Tg(Camk2a-Bdnf)A9Stl/0
(C57BL/6-Tg(Camk2a-Bdnf)A9Stl/J) 		psychomotor seizures J:216846
seizures J:216846
Tg(Camk2a-Crem)I15Endo/0
(involves: C3H * C57BL/6) 		abnormal kindling response J:137666
Tg(Camk2a-Crem)IIEndo/0
(C57BL/6-Tg(Camk2a-Crem)IIEndo) 		abnormal kindling response J:137666
Tg(Camk2a-Fyn-531)1Nko/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA) 		abnormal kindling response J:59490
abnormal seizure response to electrical stimulation J:59490
increased susceptibility to pharmacologically induced seizures J:59490
tonic seizures J:59490
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-MAPT)32Lms/0
(B6.Cg-Tg(Camk2a-tTA)1Mmay Tg(tetO-MAPT)32Lms) 		increased susceptibility to pharmacologically induced seizures J:233816
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-MAPT*A152T)L1Lms/0
(B6.Cg-Tg(Camk2a-tTA)1Mmay Tg(tetO-MAPT*A152T)L1Lms) 		increased susceptibility to pharmacologically induced seizures J:233816
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-Mtor*)#Atai/0
(involves: C57BL/6 * DBA/2 * ICR) 		seizures J:211789
Tg(Cnp-Gpr17)1Qrlu/0
(Not Specified) 		seizures J:154602
Tg(DBH-Gal)1923Stei/0
(B6.Cg-Tg(DBH-Gal)1923Stei) 		decreased susceptibility to pharmacologically induced seizures J:77625
seizures J:77625
Tg(Eno2-PTGS2)32Pasi/0
(involves: C3H/HeNTac * C57BL/6NTac) 		seizures J:100973
tonic-clonic seizures J:100973
Tg(Eno2-Scn2a1*)Q54Mm/0
(B6.Cg-Tg(Eno2-Scn2a1*)Q54Mm) 		convulsive seizures J:170734
seizures J:136510
Tg(GFAP-cre)8Gtm/0
Tsc2tm1.1Mjg/Tsc2tm1.1Mjg
(involves: 129X1/SvJ * 129S1/Sv * C57BL/6 * CBA) 		seizures J:167241
Tg(GFAP-EFNA3)181Kln/0
(involves: C57BL/6 * FVB) 		increased susceptibility to pharmacologically induced seizures J:154648
Tg(Gfap-GFAP*R239H)60TMIke/0
(involves: C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:139349
Tg(Gfap-Ifna1)12Ilc/0
(involves: BALB/c * C57BL/6J) 		seizures J:68811
Tg(Gfap-Ifna1)39Ilc/0
(involves: BALB/c * C57BL/6J) 		seizures J:68811
Tg(Gfap-Il6)G16Lms/0
Tg(Gfap-lacZ)1Lms/0
(involves: C57BL/6J * SJL) 		seizures J:125549
Tg(Gfap-Il6)G167Lms/0
(involves: C57BL/6J * SJL) 		seizures J:125549
Tg(Gfap-Il6)G167Lms/Tg(Gfap-Il6)G167Lms
(involves: C57BL/6J * SJL) 		seizures J:125549
Tg(Gfap-Il6)G369Lms/0
(involves: C57BL/6J * SJL) 		seizures J:125549
Tg(Gfap-TGFB1)64Lms/Tg(Gfap-TGFB1)64Lms
(involves: BALB/c * SJL) 		seizures J:27781
Tg(HDexon1)62Gpb/0
(involves: C57BL/6J * CBA/J) 		seizures J:36689
Tg(Lgi1*)#Mpan/0
(Not Specified) 		increased susceptibility to pharmacologically induced seizures J:154129
Tg(Lmnb1)1Yfu/0
(involves: C57BL/6J) 		abnormal spike wave discharge J:197168
clonic seizures J:197168
increased susceptibility to pharmacologically induced seizures J:197168
seizures J:197168
Tg(Mbp-Pad2)28Fgm/0
(involves: CD-1) 		convulsive seizures J:142650
Tg(Mbp-Pad2)28Fgm/Tg(Mbp-Pad2)28Fgm
(involves: CD-1) 		convulsive seizures J:142650
Tg(Mbp-SNCA)29Ema/0
(involves: C57BL/6 * DBA/2) 		seizures J:102867
Tg(MECP2)1Hzo/0
(involves: FVB) 		clonic seizures J:94407
Tg(Mov1/Tyr)OVE876BPay/Y
(FVB/N-Tg(Mov1/Tyr)OVE876BPay) 		audiogenic seizures J:167614
Tg(Mov1/Tyr)OVE876BPay/Tg(Mov1/Tyr)OVE876BPay
(FVB/N-Tg(Mov1/Tyr)OVE876BPay) 		audiogenic seizures J:167614
Tg(Pcp2-cre)2Mpin/0
Tsc2tm1.1Mjg/Tsc2tm1.2Mjg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		seizures J:174327
Tg(PLP1*)4Rsj/0
(involves: CD-1) 		environmentally induced seizures J:24069
Tg(Plp1-HTT*150Q)4aXjl/0
(Not Specified) 		increased susceptibility to pharmacologically induced seizures J:221608
Tg(Plp1-Lmnb1)#Yfu/0
(involves: FVB) 		seizures J:197168
Tg(Plp)66Kan/0
Tg(Plp)72Kan/0
(involves: C57BL/6 * DBA) 		convulsive seizures J:17373
Tg(Plp)66Kan/Tg(Plp)66Kan
(involves: C57BL * DBA) 		seizures J:17373
Tg(Plp)66Kan/Tg(Plp)66Kan
(B6NCrl.Cg-Tg(Plp)66Kan) 		seizures J:156106
Tg(Prnp*)#Rgab/0
(involves: C57BL/6 * FVB/N) 		myoclonus J:183170
Tg(Prnp-ATN1)150Dbo/?
(involves: C3H * C57BL/6) 		seizures J:70362
Tg(Prnp-ATXN3)BVcg/Tg(Prnp-ATXN3)BVcg
(involves: C3H/HeJ * C57BL/6) 		seizures J:96574
Tg(Prnp-ATXN3)CVcg/Tg(Prnp-ATXN3)CVcg
(involves: C3H/HeJ * C57BL/6) 		seizures J:96574
Tg(Prnp-lacZ/ATXN10*)#Teas/0
(involves: FVB/N) 		increased susceptibility to pharmacologically induced seizures J:222081
Tg(Prnp-MAPT*)2652Gds/Tg(Prnp-MAPT*)2652Gds
(B6.Cg-Tg(Prnp-MAPT*)2652Gds) 		seizures J:244052
Tg(Prnp-TBP*)71-16Xjl/0
(FVB/N-Tg(Prnp-TBP*)71-16Xjl) 		sporadic seizures J:130775
Tg(Prnp-TBP*)71-27Xjl/0
(FVB/N-Tg(Prnp-TBP*)71-27Xjl) 		sporadic seizures J:130775
Tg(Prnp-TBP*)105Xjl/0
(FVB/N-Tg(Prnp-TBP*)105Xjl) 		sporadic seizures J:130775
Tg(Prnp-tTA)F959Sbp/0
Tg(tetO-Chrnb2*V287L)H3Gica/0
(involves: 129S7/SvEvBrd * FVB) 		seizures J:145855
Tg(Prnp-tTA)F959Sbp/?
Tg(TetO-Nfkbia*S32A*S36A)1Wcg/?
(involves: 129S7/SvEvBrd * DBA * FVB/N) 		environmentally induced seizures J:112973
Tg(RP23-65I14)1Jno/?
(involves: FVB) 		absence seizures J:146431
Tg(RP23-65I14)2Jno/?
(involves: FVB/N) 		absence seizures J:146431
Tg(Scn1a*)RH9Aesc/0
(involves: FVB/NJ) 		increased susceptibility to pharmacologically induced seizures J:150454
Tg(Shank3-EGFP)1Hzo/0
(involves: FVB/N) 		seizures J:201867
Tg(Tek-tTA)1Rwng/0
Tg(tetO-Notch4*)1Rwng/0
(involves: FVB/N) 		seizures J:139943
Tg(Thy1-APP)4Vln/0
(involves: FVB/N) 		seizures J:53800
Tg(Thy1-App*R609D*K612E)2Vln/0
(involves: C57BL * CBA/J) 		seizures J:32213
Tg(Thy1-App*R609D*K612E)4Vln/0
(involves: FVB) 		clonic seizures J:32213
myoclonus J:32213
seizures J:32213
tonic-clonic seizures J:32213
Tg(Thy1-App*R609D*K612E)4Vln/Tg(Thy1-App*R609D*K612E)4Vln
(involves: FVB) 		clonic seizures J:32213
decreased susceptibility to pharmacologically induced seizures J:32213
increased susceptibility to pharmacologically induced seizures J:32213
myoclonus J:32213
seizures J:32213
tonic-clonic seizures J:32213
Tg(Thy1-App*R609D*K612E)6Vln/0
(involves: FVB) 		clonic seizures J:32213
myoclonus J:32213
seizures J:32213
tonic-clonic seizures J:32213
Tg(Thy1-App*R609D*K612E)6Vln/Tg(Thy1-App*R609D*K612E)6Vln
(involves: FVB) 		clonic seizures J:32213
decreased susceptibility to pharmacologically induced seizures J:32213
increased susceptibility to pharmacologically induced seizures J:32213
myoclonus J:32213
seizures J:32213
tonic-clonic seizures J:32213
Tg(Thy1-APPLon)2Vln/0
(involves: FVB/N) 		seizures J:53800
Tg(Thy1-APPSw)1Vln/0
(involves: FVB/N) 		seizures J:53800
Tg(Thy1-MAPT*)1Avil/Tg(Thy1-MAPT*)1Avil
(involves: C57BL/6 * CBA) 		increased susceptibility to pharmacologically induced seizures J:201700
myoclonus J:201700
nonconvulsive seizures J:201700
seizures J:201700
tonic-clonic seizures J:201700
Tg(Thy1-SERPINI1*G392E)333Icka/0
(involves: C57BL * CD-1 * DBA) 		increased susceptibility to pharmacologically induced seizures J:144649
Tg(Thy1-SERPINI1*G392E)333Icka/Tg(Thy1-SERPINI1*G392E)333Icka
(involves: C57BL * CD-1 * DBA) 		increased susceptibility to pharmacologically induced seizures J:144649
Tg(UBC-Adk)1Bois/0
(B6;129P3-Adktm1Bois Tg(UBC-Adk)1Bois) 		abnormal seizure response to pharmacological agent J:105483
nonconvulsive seizures J:105483
Thrbtm1Df/Thrbtm1Df
(either: B6.129S1-Thrbtm1Df or (involves: 129S1/Sv * C57BL/6J)) 		audiogenic seizures J:103702
Tinf2tm2.2Tdl/Tinf2+
(involves: BALB/cJ * C57BL/6) 		seizures J:207367
tmgc61/tmgc61
(Mixed stock) 		decreased susceptibility to pharmacologically induced seizures J:92490
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6) 		seizures J:112713
Tpp1tm1Dgen/Tpp1tm1Dgen
(involves: 129S1/Sv * C57BL/6) 		seizures J:101679
Tpp1tm1Plob/Tpp1tm1Plob
(involves: 129S1/Sv * C57BL/6) 		audiogenic seizures J:94884
Tppptm1.1(KOMP)Vlcg/Tppptm1.1(KOMP)Vlcg
(C57BL/6N-Tppptm1.1(KOMP)Vlcg/J) 		convulsive seizures J:211773
Trim2Gt(IRESBetageo)11Pgr/Trim2Gt(IRESBetageo)11Pgr
(involves: 129/Sv * C57BL/6) 		seizures J:140337
Trim3tm1Mak/Trim3tm1Mak
(B6.129P2-Trim3tm1Mak) 		decreased susceptibility to pharmacologically induced seizures J:161372
Trp53tm1Elee/Trp53tm1Elee
Tg(GFAP-cre)25Mes/0
(involves: 129S4/SvJae * FVB/N) 		seizures J:149662
Trp53tm1Elee/Trp53tm1Tyj
Tg(GFAP-cre)25Mes/0
(involves: 129S2/SvPas * 129S4/SvJae * FVB/N) 		seizures J:149662
Trpc5tm1.1Lbi/Y
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		decreased susceptibility to pharmacologically induced seizures J:194590
Trpc5tm1.1Lbi/Trpc5tm1.1Lbi
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		decreased susceptibility to pharmacologically induced seizures J:194590
Trpm7tm1Agry/Trpm7+
(involves: 129) 		seizures J:205665
Tsc1tm1Djk/Tsc1tm1.1Djk
Tg(Syn1-cre)671Jxm/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		seizures J:121858
sporadic seizures J:121858
Tsc1tm1Djk/Tsc1tm1Djk
Tg(GFAP-cre)8Gtm/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		seizures J:116872, J:167241
Tsc1tm1Djk/Tsc1tm1Djk
Tg(GFAP-cre)#Gtm/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		seizures J:176586
Tsc2tm1.1Kcess/Tsc2tm1.1Kcess
Emx1tm1(cre)Krj/Emx1+
(involves: 129S/Sv * C57BL/6J) 		environmentally induced seizures J:195049
tsl/tsl
(CByJNarl(B6NTacTcu)-tsl) 		seizures J:275934
Ty/Y
((129P3/J x NZB/BlNJ)F1) 		seizures J:13773
Tyl/Y
(involves: A/J * C57BL/6J) 		seizures J:14294
Tyro3tm1Grl/Tyro3tm1Grl
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal seizure response to inducing agent J:54681
Ube3atm1Alb/Ube3a+
(involves: 129S7/SvEvBrd * C57BL/6) 		absence seizures J:50811
audiogenic seizures J:50811
tonic-clonic seizures J:50811
Ube3atm1Alb/Ube3a+
(involves: 129S7/SvEvBrd) 		audiogenic seizures J:50811
tonic-clonic seizures J:50811
Ube3atm1Alb/Ube3atm1Alb
(involves: 129S7/SvEvBrd * C57BL/6) 		audiogenic seizures J:50811
Ube3atm1Alb/Ube3atm1Alb
(involves: 129S7/SvEvBrd) 		audiogenic seizures J:50811
Ube3atm1Jwf/Ube3a+
(B6.129S4-Ube3atm1Jwf) 		abnormal spike wave discharge J:75622, J:102546, J:95305
Ube3atm1Yelg/Ube3a+
(involves: 129P2/OlaHsd * 129S2/SvPasCrl) 		audiogenic seizures J:222400
Ugt1tm1.1Afmu/Ugt1tm1.1Afmu
(FVB.Cg-Ugt1tm1.1Afmu) 		seizures J:216224
Unc13btm1Rmnd/Unc13btm1Rmnd
(Not Specified) 		sporadic seizures J:77339
Usf1tm1Msw/Usf1tm1Msw
(involves: 129S7/SvEvBrd * C57BL/6) 		environmentally induced seizures J:46788
sporadic seizures J:46788
Usf2tm1Msw/Usf2tm1Msw
(involves: 129S7/SvEvBrd * C57BL/6) 		sporadic seizures J:46788
Usp18tm1Dez/Usp18tm1Dez
(involves: 129S1/Sv * 129X1/SvJ) 		convulsive seizures J:78821
Vcptm1Itl/Vcp+
(B6.129S-Vcptm1Itl) 		seizures J:166230
tonic-clonic seizures J:166230
Xrcc1tm1Pmc/Xrcc1tm1Pmc
Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * C57BL/6 * SJL) 		seizures J:152528
Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: C57BL/6 * DBA/2) 		increased susceptibility to pharmacologically induced seizures J:121330
Zfp24hmcns-2J/Zfp24hmcns-2J
(CByJ(Cg)-Zfp24hmcns-2J/GrsrJ) 		tonic seizures J:202595
Zfp24hmcns/Zfp24hmcns
(C3.Cg-a Zfp24hmcns/GrsrJ) 		tonic seizures J:156938
Zfp24tm1.1Pop/Zfp24tm1.1Pop
Cnptm1(cre)Kan/Cnp+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		tonic seizures J:156938
Zfp24tm1.2Pop/Zfp24tm1.2Pop
(involves: 129S4/SvJae * C57BL/6) 		tonic seizures J:156938
Zfp597tm1Hnawa/Zfp597+
(B6.Cg-Zfp597tm1Hnawa) 		seizures J:278329
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support. 		last database update
05/19/2020
MGI 6.15 		The Jackson Laboratory